All medical conferences moved to a virtual meeting format due to COVID-19 this year, and there has been apprehension that virtual formats do not allow the same feeling and face-to-face collaboration. However, some medical societies are finding the format enables more international physician participation.

The Society of Cardiovascular Computed Tomography (SCCT) gave its 2020 Gold Metal Award to computed tomography (CT) pioneer John Lesser, M.D., MSCCT, director of advanced imaging and cardiac CT, Minneapolis Heart Institute, Abbott Northwestern Hospital. It was awarded at the SCCT virtual meeting in July.

GE Vscan Extent LVivo EF app tutorial
Video Player is loading.
Current Time 0:00
Duration 2:51
Loaded: 0%
Stream Type LIVE
Remaining Time 2:51
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected

    This is a tutorial video on how to perform an artificial intelligence (AI) automated cardiac ejection fraction measurement using the GE Healthcare Vscan Extend point-of-care ultrasound (POCUS) system and the LVivo EF app, developed and licensed by DiA Imaging Analysis. This FDA-cleared app enables an automated edge detection of left ventricular endocardium and calculates end-diastolic, end-systolic volumes and ejection fraction, using apical 4-chamber view.

    the LVivo EF app was showcased by GE Healthcare in its virtual booth at the American Society of Echocardiography (ASE) 2020 virtual meeting. POCUS imaging has emerged as a primary imaging modality for bedside assessment of COVID-19 patients in 2020.

     

    Related ASE News and POCUS Content:

    VIDEO: Automated Cardiac Ejection Fraction for Point-of-care-ultrasound Using Artificial Intelligence

    LVivo EF Comparable to MRI, Contrast Echo in Assessing Ejection Fraction

    GE Highlights New Echocardiography Technologies at ASE 2020

    Other ASE news and video

     

    Recent Videos View all 660 items

    January 30, 2025

    On July 16, 2024, Diagnostic and Interventional Cardiology presented a webinar on "Maximizing Structural Heart Workflows: Harnessing the Power of CVIS and AI." 

    During the webinar, Omer Schalit–Cohen, chief product officer at Optum’s Healthcare Enterprising Imaging business unit, addressed optimizing workflow and efficiencies in the cardiovascular imaging department.  In the presentation, Cohen examines how you can harness the power of the CVIS and AI technologies to enhance structural heart workflow in the EP lab and ultrasound procedures.

    Schalit–Cohen is the chief product officer at Optum’s Healthcare Enterprising Imaging business unit. With more than 20 years of experience in innovation, he is an expert in the Imaging’s department complex workflows and has been instrumental in driving market leading solutions that have significantly enhanced patient care and department’s efficiency. as well as customer satisfaction.
     

    Company Profile

    The webinar is sponsored by Optum, a leading information and technology-enabled health services business dedicated to helping make the health system work better for everyone. With more than 215,000 people worldwide, Optum delivers intelligent, integrated solutions that help to modernize the health system and improve overall population health. Optum is part of UnitedHealth Group.

    For more information, visit optum.com.

    January 07, 2025

    On Jan. 10, 2024, Diagnostic and Interventional Cardiology presented a webinar on "Contrast Management in Modern PCI." 

    Dr. Aditya Sharma, MD, MBA, FACC, FSCAI, an interventional cardiologist from Wellspan Health in Central Pennsylvania was the presenter. The webinar is sponsored by ACIST Medical Systems.

    In the cardiac cath lab, the use of iodinated contrast in both diagnostic and PCI procedures is commonplace. The effects of iodinated contrast on renal function have been known and researched. However, conversations are ongoing around best practices and standards of care regarding contrast management and treatment for those with higher risk factors, like compromised renal function. Participate in this webinar to gain insight on the topic of contrast-induced kidney injury and how one could approach contrast management in modern PCI with use of the ACIST CVi Contrast Delivery System.

    Learning Objectives

    * Understand basic mechanisms of contrast induced kidney injury.
    * Determine incidence of disease along with long term patient and economic implications.
    * Review risk factors determining higher risk populations.
    * Evaluate device strategy in modern era to mitigate risk and promote procedural efficiency and safety.
    * Case review of use of the ACIST CVi Contrast Delivery System in high risk patient. 

    Dr. Aditya Sharma
    Dr Aditya Sharma

    Dr. Sharma is board certified in internal medicine, cardiovascular disease, and interventional cardiology, having completed both residency and fellowship programs at George Washington University - School of Medicine and Hospital. He chose a career in medicine to be able to help others while being able to continuously enrich his skills and apply learned scientific knowledge.

    About ACIST

    Physicians worldwide rely on our diagnostic technologies to give them the power to visualize, assess and inform patient treatment. ACIST informs interventional decisions during peripheral, cardiovascular disease and structural heart procedures. Economic decision-makers appreciate our ability to demonstrate the value of therapeutic intervention.

    January 01, 2025

    Preventing contrast induced nephropathy and managing patients with chronic kidney disease remain major challenges in the cardiac catheterization lab. In recent years, contrast supply shortages have presented a new challenge to care delivery. When considering these challenges, and as quality metrics in our labs face more scrutiny, there are existing technologies and best practices such as a variable rate contrast delivery systems and HD IVUS that can be used to manage workflow and improve patient outcomes.

    The ACC Interventional Council’s recent statement recommending that intracoronary imaging be a routine part of clinical practice further reinforces the need for adoption of intracoronary. Using a case-based approach, the faculty will demonstrate how to use the ACIST CVi contrast delivery system, HDi high definition IVUS and diagnostic and post-PCI physiologic assessment to reduce contrast usage, improve AKI rates and deliver optimized patient outcomes.

    Learning Objectives

    By the end of this webinar, participants will understand that high-quality care starts at the point of education and can transform cardiovascular imaging. Attendees will see how optimized workflows can improve quality and will be able to:

    • To understand the benefits of implementing a variable rate contrast delivery system in the cath lab.

    • To understand the clinical benefits of HD IVUS utilization and how to implement a standardized workflow for effective use.

    • To understand how HD IVUS and physiologic testing can be used to improve patient outcomes and reduce contrast utilization.

    Featured Speakers

    headshot

    Dr. Matheen A. Khuddus, Director of Cardiovascular Research/Director of the Cardiac Catheterization Lab, HCA Florida North Florida Hospital and the Cardiac & Vascular Institute, Gainesville, Fla.

    Dr. Khuddus is an interventional cardiologist who currently serves as the Director of Cardiovascular Research and the Director of the Cardiac Catheterization Lab as well as a National Physician Director for HCA Healthcare. He is a fellow of the ACC and SCAI.  He is board certified in Cardiovascular Medicine, Interventional Cardiology, and Internal Medicine.  He is also an AHSCP Clinical Hypertension Specialist.



    headshot

    Dr. Darshan Doshi, Director of Complex Coronary Artery Disease, Massachusetts General Hospital, Boston, Mass.

    Dr. Doshi is an interventional cardiologist who specializes in complex coronary intervention, specifically chronic total occlusions, surgical turndowns, ultralow and zero contrast stenting procedures, and treatment of recurrent stent blockages. He is the Director of Complex Coronary Artery Disease at MGH. He is board certified in Cardiovascular Medicine and Interventional Cardiology.

    About ACIST

    Physicians worldwide rely on our diagnostic technologies to give them the power to visualize, assess and inform patient treatment. ACIST informs interventional decisions during peripheral, cardiovascular disease and structural heart procedures. Economic decision-makers appreciate our ability to demonstrate the value of therapeutic intervention.

    January 24, 2025

    Behavioral science is being applied in unique ways for enterprise-imaging product design.

    Behavioral science is the study of human behavior. It’s a mix of psychology, sociology, social and cultural anthropology, and economics. Using a data-driven, human-centered approach, behavioral science helps uncover what people have done in the past and tries to predict — and often change — how they’ll behave in the future.

    In this webinar, leading healthcare experts will discuss how observation, interviews, and experimentation can help the industry form a better understanding of current customer needs and pain points within cardiovascular imaging. Having clinicians involved in the product-design process has led to the complete rearchitecting of a next-generation hemodynamics solution.

    Using a real-world scenario, we’ll share a clinician’s experience working with behavioral science and product-development teams, provide an understanding of how they’re using hemodynamics today, and get their thoughts on the future of imaging and hemodynamics.

    By listening to key stakeholders, new features can be brought to market that will have a notable impact on the way health systems operate. By building better products, we can help improve patient outcomes and ultimately transform the healthcare industry — one behavior at a time.

    Learning Objectives

    • How a next-generation hemodynamics system has implemented 19 user-centric concepts and undergone iterative testing with healthcare providers.

    • How physicians, technicians, nurses and administrators are providing their expertise to bring new features to market that will have a notable impact on the way health systems operate.

    • What a next-generation hemodynamics system can do to keep pace with new technology innovations in cardiovascular care and increasing clinical demands.

    Featured Speakers

    James Stinnett

    James Stinnett, Behavioral Scientist, Change Healthcare

    James Stinnett is an experienced researcher with a background in product, UX, and behavioral science. He joined Change Healthcare three years ago and is currently a researcher on the behavioral science team.

    Dr. Barry Bertolet

    Dr. Barry Bertolet, Interventional Cardiologist and Director of Cardiac Catheterization Laboratory, North Mississippi Medical Center

    Dr. Barry Bertolet champions the education of physicians and patients throughout the region and has participated in numerous research trials exploring early detection and treatment of cardiovascular diseases. He is a founding member of the Mississippi Health Care Alliance, an organization which has developed the nation’s first statewide system of care for both heart attack and stroke. He is also board certified by the American Board of Internal Medicine in cardiovascular disease, internal medicine and interventional cardiology.

    About Change Healthcare

    Change Healthcare is a leading independent healthcare technology company, focused on insights, innovation and accelerating the transformation of the healthcare system through the power of the Change Healthcare platform. We provide data and analytics-driven solutions to improve clinical, financial, administrative, and patient engagement outcomes in the U.S. healthcare system.

    Sponsored Videos View all 46 items

    Cardiovascular Ultrasound | July 20, 2022

    Enhanced features on the Philips EPIQ CVx ultrasound system provide a next level photorealistic 3D rendering, making it easy for users to interpret what they are seeing. The TrueVue feature enhances the sense of depth and space, producing images that appear natural and realistic to the human eye.  

    Watch the video to check out how TrueVue can help improve views of LAA and MV morphology. 

    Cardiovascular Ultrasound | July 07, 2022

    Automated features on the Philips EPIQ CVx cardiology ultrasound system are helping to bring consistency and speed to every echo exam. The AI-empowered algorithm delivers fast and consistent measurements – in half the time of manual methods.*  

    Watch the video to see how you can put “smart”  to work with the latest AI-powered quantification tools. 

    *External study with external sonographers comparing the results of 18 exams with and without AutoMeasure

    Cardiovascular Ultrasound | June 14, 2022

    The X5-1c transducer from Philips provides enhanced clinical information in transthoracic imaging over a standard phased array transducer. When combined with nSIGHT Plus image formation on the EPIQ CVx cardiology ultrasound system, the X5-1c transducer enables image quality rarely seen from a transthoracic transducer. 

    Watch the video to learn about the benefits which may include decreased exam time due to faster access to echo windows, increased confidence in quantification results and more. 

    Cardiovascular Ultrasound | May 31, 2022

    Philips recently announced an update to their flagship EPIQ CVx premium cardiology ultrasound system. Watch the video to learn about the latest features including the next-generation nSIGHT Plus imaging architecture system that leverages both hardware and software to support sophisticated image formation and enhanced image quality.

    Conference Coverage View all 467 items

    Cardiovascular Clinical Studies | July 30, 2024

    As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

    As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

    His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

    Related content:

    DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

    DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

     

    HIMSS | July 24, 2024

    Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

    Find more HIMSS24 conference coverage here

    A New Partnership for Growth

    Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

    Exciting New Features at HIMSS24

    At HIMSS2024, with this new collaboration comes new features, including:

    Related content:

    Find more HIMSS24 conference coverage here

    HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

    Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

    VIDEO: Using Maturity Models to Measure Digital Health

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    Information Technology | May 17, 2023

    HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

    Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

    Find more HIMSS23 coverage here

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

     

    Related Digital Transformation Content:

    Robocath Launches New Robotic Platform R-One+

    VIDEO: Using Maturity Models to Measure Digital Health

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    New ACC President Defines Priorities for Year Ahead

    Health That Connects + Tech That Cares at HIMSS 2023

    ACC22: Transforming Cardiovascular Care

     

     

    Information Technology | May 11, 2023

    Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

    Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

    Find more HIMSS23 coverage here

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    Related Digital Transformation Content:

    Robocath Launches New Robotic Platform R-One+

    VIDEO: Using Maturity Models to Measure Digital Health

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    New ACC President Defines Priorities for Year Ahead

    Health That Connects + Tech That Cares at HIMSS 2023

    ACC22: Transforming Cardiovascular Care

    Cath Lab View all 316 items

    Cardiovascular Clinical Studies | July 30, 2024

    As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

    As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

    His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

    Related content:

    DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

    DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

     

    HIMSS | July 24, 2024

    Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

    Find more HIMSS24 conference coverage here

    A New Partnership for Growth

    Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

    Exciting New Features at HIMSS24

    At HIMSS2024, with this new collaboration comes new features, including:

    Related content:

    Find more HIMSS24 conference coverage here

    HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

    Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

    VIDEO: Using Maturity Models to Measure Digital Health

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    Information Technology | May 17, 2023

    HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

    Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

    Find more HIMSS23 coverage here

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

     

    Related Digital Transformation Content:

    Robocath Launches New Robotic Platform R-One+

    VIDEO: Using Maturity Models to Measure Digital Health

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    New ACC President Defines Priorities for Year Ahead

    Health That Connects + Tech That Cares at HIMSS 2023

    ACC22: Transforming Cardiovascular Care

     

     

    Information Technology | May 11, 2023

    Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

    Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

    Find more HIMSS23 coverage here

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    Related Digital Transformation Content:

    Robocath Launches New Robotic Platform R-One+

    VIDEO: Using Maturity Models to Measure Digital Health

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    New ACC President Defines Priorities for Year Ahead

    Health That Connects + Tech That Cares at HIMSS 2023

    ACC22: Transforming Cardiovascular Care

    Cardiac Imaging View all 289 items

    Cardiovascular Clinical Studies | July 30, 2024

    As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

    As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

    His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

    Related content:

    DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

    DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

     

    HIMSS | July 24, 2024

    Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

    Find more HIMSS24 conference coverage here

    A New Partnership for Growth

    Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

    Exciting New Features at HIMSS24

    At HIMSS2024, with this new collaboration comes new features, including:

    Related content:

    Find more HIMSS24 conference coverage here

    HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

    Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

    VIDEO: Using Maturity Models to Measure Digital Health

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    Information Technology | May 17, 2023

    HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

    Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

    Find more HIMSS23 coverage here

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

     

    Related Digital Transformation Content:

    Robocath Launches New Robotic Platform R-One+

    VIDEO: Using Maturity Models to Measure Digital Health

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    New ACC President Defines Priorities for Year Ahead

    Health That Connects + Tech That Cares at HIMSS 2023

    ACC22: Transforming Cardiovascular Care

     

     

    Information Technology | May 11, 2023

    Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

    Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

    Find more HIMSS23 coverage here

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    Related Digital Transformation Content:

    Robocath Launches New Robotic Platform R-One+

    VIDEO: Using Maturity Models to Measure Digital Health

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    New ACC President Defines Priorities for Year Ahead

    Health That Connects + Tech That Cares at HIMSS 2023

    ACC22: Transforming Cardiovascular Care

    Cardiac Diagnostics View all 78 items

    Cardiovascular Clinical Studies | July 30, 2024

    As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

    As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

    His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

    Related content:

    DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

    DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

     

    HIMSS | July 24, 2024

    Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

    Find more HIMSS24 conference coverage here

    A New Partnership for Growth

    Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

    Exciting New Features at HIMSS24

    At HIMSS2024, with this new collaboration comes new features, including:

    Related content:

    Find more HIMSS24 conference coverage here

    HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

    Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

    VIDEO: Using Maturity Models to Measure Digital Health

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    Information Technology | May 17, 2023

    HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

    Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

    Find more HIMSS23 coverage here

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

     

    Related Digital Transformation Content:

    Robocath Launches New Robotic Platform R-One+

    VIDEO: Using Maturity Models to Measure Digital Health

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    New ACC President Defines Priorities for Year Ahead

    Health That Connects + Tech That Cares at HIMSS 2023

    ACC22: Transforming Cardiovascular Care

     

     

    Information Technology | May 11, 2023

    Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

    Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

    Find more HIMSS23 coverage here

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    Related Digital Transformation Content:

    Robocath Launches New Robotic Platform R-One+

    VIDEO: Using Maturity Models to Measure Digital Health

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    New ACC President Defines Priorities for Year Ahead

    Health That Connects + Tech That Cares at HIMSS 2023

    ACC22: Transforming Cardiovascular Care

    EP Lab View all 83 items

    Cardiovascular Clinical Studies | July 30, 2024

    As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

    As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

    His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

    Related content:

    DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

    DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

     

    HIMSS | July 24, 2024

    Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

    Find more HIMSS24 conference coverage here

    A New Partnership for Growth

    Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

    Exciting New Features at HIMSS24

    At HIMSS2024, with this new collaboration comes new features, including:

    Related content:

    Find more HIMSS24 conference coverage here

    HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

    Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

    VIDEO: Using Maturity Models to Measure Digital Health

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    Information Technology | May 17, 2023

    HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

    Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

    Find more HIMSS23 coverage here

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

     

    Related Digital Transformation Content:

    Robocath Launches New Robotic Platform R-One+

    VIDEO: Using Maturity Models to Measure Digital Health

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    New ACC President Defines Priorities for Year Ahead

    Health That Connects + Tech That Cares at HIMSS 2023

    ACC22: Transforming Cardiovascular Care

     

     

    Information Technology | May 11, 2023

    Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

    Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

    Find more HIMSS23 coverage here

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    Related Digital Transformation Content:

    Robocath Launches New Robotic Platform R-One+

    VIDEO: Using Maturity Models to Measure Digital Health

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    New ACC President Defines Priorities for Year Ahead

    Health That Connects + Tech That Cares at HIMSS 2023

    ACC22: Transforming Cardiovascular Care

    Information Technology View all 177 items

    Cardiovascular Clinical Studies | July 30, 2024

    As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

    As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

    His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

    Related content:

    DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

    DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

     

    HIMSS | July 24, 2024

    Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

    Find more HIMSS24 conference coverage here

    A New Partnership for Growth

    Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

    Exciting New Features at HIMSS24

    At HIMSS2024, with this new collaboration comes new features, including:

    Related content:

    Find more HIMSS24 conference coverage here

    HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

    Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

    VIDEO: Using Maturity Models to Measure Digital Health

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    Information Technology | May 17, 2023

    HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

    Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

    Find more HIMSS23 coverage here

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

     

    Related Digital Transformation Content:

    Robocath Launches New Robotic Platform R-One+

    VIDEO: Using Maturity Models to Measure Digital Health

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    New ACC President Defines Priorities for Year Ahead

    Health That Connects + Tech That Cares at HIMSS 2023

    ACC22: Transforming Cardiovascular Care

     

     

    Information Technology | May 11, 2023

    Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

    Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

    Find more HIMSS23 coverage here

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    Related Digital Transformation Content:

    Robocath Launches New Robotic Platform R-One+

    VIDEO: Using Maturity Models to Measure Digital Health

    VIDEO: Moving Digital Transformation Forward in Healthcare

    VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

    VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

    VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

    New ACC President Defines Priorities for Year Ahead

    Health That Connects + Tech That Cares at HIMSS 2023

    ACC22: Transforming Cardiovascular Care

    Medis developing strain analysis for CT and MRI
    Video Player is loading.
    Current Time 0:00
    Duration 0:44
    Loaded: 0%
    Stream Type LIVE
    Remaining Time 0:44
     
    1x
      • Chapters
      • descriptions off, selected
      • captions off, selected
      • en (Main), selected

      Advanced visualization company Medis recently purchased Advanced Medical Imaging Development S.r.l. (AMID), which developed software to automatically track and measure strain in echocardiograms. That technology is now being adapted for strain imaging in CT and MRI. Using this imaging data, the software also can noninvasively derive pressure gradient loops and curves, similar to using invasive pulmonary arterial (PA) hemodynamic pressure catheters. This information is useful in monitoring critically ill patients on hemodynamic support and to monitor worsening severity of heart failure. 

      The technology was discussed at the 2020 Society of Cardiovascular Computed Tomography (SCCT) virtual meeting. Examples of this technology are presented in this video. 
       

      Find more news and video from SCCT 2020

      VIDEO: Photon Counting Detectors Will be the Next Major Advance in Computed Tomography
       

      Recent Videos View all 660 items

      January 30, 2025

      On July 16, 2024, Diagnostic and Interventional Cardiology presented a webinar on "Maximizing Structural Heart Workflows: Harnessing the Power of CVIS and AI." 

      During the webinar, Omer Schalit–Cohen, chief product officer at Optum’s Healthcare Enterprising Imaging business unit, addressed optimizing workflow and efficiencies in the cardiovascular imaging department.  In the presentation, Cohen examines how you can harness the power of the CVIS and AI technologies to enhance structural heart workflow in the EP lab and ultrasound procedures.

      Schalit–Cohen is the chief product officer at Optum’s Healthcare Enterprising Imaging business unit. With more than 20 years of experience in innovation, he is an expert in the Imaging’s department complex workflows and has been instrumental in driving market leading solutions that have significantly enhanced patient care and department’s efficiency. as well as customer satisfaction.
       

      Company Profile

      The webinar is sponsored by Optum, a leading information and technology-enabled health services business dedicated to helping make the health system work better for everyone. With more than 215,000 people worldwide, Optum delivers intelligent, integrated solutions that help to modernize the health system and improve overall population health. Optum is part of UnitedHealth Group.

      For more information, visit optum.com.

      January 07, 2025

      On Jan. 10, 2024, Diagnostic and Interventional Cardiology presented a webinar on "Contrast Management in Modern PCI." 

      Dr. Aditya Sharma, MD, MBA, FACC, FSCAI, an interventional cardiologist from Wellspan Health in Central Pennsylvania was the presenter. The webinar is sponsored by ACIST Medical Systems.

      In the cardiac cath lab, the use of iodinated contrast in both diagnostic and PCI procedures is commonplace. The effects of iodinated contrast on renal function have been known and researched. However, conversations are ongoing around best practices and standards of care regarding contrast management and treatment for those with higher risk factors, like compromised renal function. Participate in this webinar to gain insight on the topic of contrast-induced kidney injury and how one could approach contrast management in modern PCI with use of the ACIST CVi Contrast Delivery System.

      Learning Objectives

      * Understand basic mechanisms of contrast induced kidney injury.
      * Determine incidence of disease along with long term patient and economic implications.
      * Review risk factors determining higher risk populations.
      * Evaluate device strategy in modern era to mitigate risk and promote procedural efficiency and safety.
      * Case review of use of the ACIST CVi Contrast Delivery System in high risk patient. 

      Dr. Aditya Sharma
      Dr Aditya Sharma

      Dr. Sharma is board certified in internal medicine, cardiovascular disease, and interventional cardiology, having completed both residency and fellowship programs at George Washington University - School of Medicine and Hospital. He chose a career in medicine to be able to help others while being able to continuously enrich his skills and apply learned scientific knowledge.

      About ACIST

      Physicians worldwide rely on our diagnostic technologies to give them the power to visualize, assess and inform patient treatment. ACIST informs interventional decisions during peripheral, cardiovascular disease and structural heart procedures. Economic decision-makers appreciate our ability to demonstrate the value of therapeutic intervention.

      January 01, 2025

      Preventing contrast induced nephropathy and managing patients with chronic kidney disease remain major challenges in the cardiac catheterization lab. In recent years, contrast supply shortages have presented a new challenge to care delivery. When considering these challenges, and as quality metrics in our labs face more scrutiny, there are existing technologies and best practices such as a variable rate contrast delivery systems and HD IVUS that can be used to manage workflow and improve patient outcomes.

      The ACC Interventional Council’s recent statement recommending that intracoronary imaging be a routine part of clinical practice further reinforces the need for adoption of intracoronary. Using a case-based approach, the faculty will demonstrate how to use the ACIST CVi contrast delivery system, HDi high definition IVUS and diagnostic and post-PCI physiologic assessment to reduce contrast usage, improve AKI rates and deliver optimized patient outcomes.

      Learning Objectives

      By the end of this webinar, participants will understand that high-quality care starts at the point of education and can transform cardiovascular imaging. Attendees will see how optimized workflows can improve quality and will be able to:

      • To understand the benefits of implementing a variable rate contrast delivery system in the cath lab.

      • To understand the clinical benefits of HD IVUS utilization and how to implement a standardized workflow for effective use.

      • To understand how HD IVUS and physiologic testing can be used to improve patient outcomes and reduce contrast utilization.

      Featured Speakers

      headshot

      Dr. Matheen A. Khuddus, Director of Cardiovascular Research/Director of the Cardiac Catheterization Lab, HCA Florida North Florida Hospital and the Cardiac & Vascular Institute, Gainesville, Fla.

      Dr. Khuddus is an interventional cardiologist who currently serves as the Director of Cardiovascular Research and the Director of the Cardiac Catheterization Lab as well as a National Physician Director for HCA Healthcare. He is a fellow of the ACC and SCAI.  He is board certified in Cardiovascular Medicine, Interventional Cardiology, and Internal Medicine.  He is also an AHSCP Clinical Hypertension Specialist.



      headshot

      Dr. Darshan Doshi, Director of Complex Coronary Artery Disease, Massachusetts General Hospital, Boston, Mass.

      Dr. Doshi is an interventional cardiologist who specializes in complex coronary intervention, specifically chronic total occlusions, surgical turndowns, ultralow and zero contrast stenting procedures, and treatment of recurrent stent blockages. He is the Director of Complex Coronary Artery Disease at MGH. He is board certified in Cardiovascular Medicine and Interventional Cardiology.

      About ACIST

      Physicians worldwide rely on our diagnostic technologies to give them the power to visualize, assess and inform patient treatment. ACIST informs interventional decisions during peripheral, cardiovascular disease and structural heart procedures. Economic decision-makers appreciate our ability to demonstrate the value of therapeutic intervention.

      January 24, 2025

      Behavioral science is being applied in unique ways for enterprise-imaging product design.

      Behavioral science is the study of human behavior. It’s a mix of psychology, sociology, social and cultural anthropology, and economics. Using a data-driven, human-centered approach, behavioral science helps uncover what people have done in the past and tries to predict — and often change — how they’ll behave in the future.

      In this webinar, leading healthcare experts will discuss how observation, interviews, and experimentation can help the industry form a better understanding of current customer needs and pain points within cardiovascular imaging. Having clinicians involved in the product-design process has led to the complete rearchitecting of a next-generation hemodynamics solution.

      Using a real-world scenario, we’ll share a clinician’s experience working with behavioral science and product-development teams, provide an understanding of how they’re using hemodynamics today, and get their thoughts on the future of imaging and hemodynamics.

      By listening to key stakeholders, new features can be brought to market that will have a notable impact on the way health systems operate. By building better products, we can help improve patient outcomes and ultimately transform the healthcare industry — one behavior at a time.

      Learning Objectives

      • How a next-generation hemodynamics system has implemented 19 user-centric concepts and undergone iterative testing with healthcare providers.

      • How physicians, technicians, nurses and administrators are providing their expertise to bring new features to market that will have a notable impact on the way health systems operate.

      • What a next-generation hemodynamics system can do to keep pace with new technology innovations in cardiovascular care and increasing clinical demands.

      Featured Speakers

      James Stinnett

      James Stinnett, Behavioral Scientist, Change Healthcare

      James Stinnett is an experienced researcher with a background in product, UX, and behavioral science. He joined Change Healthcare three years ago and is currently a researcher on the behavioral science team.

      Dr. Barry Bertolet

      Dr. Barry Bertolet, Interventional Cardiologist and Director of Cardiac Catheterization Laboratory, North Mississippi Medical Center

      Dr. Barry Bertolet champions the education of physicians and patients throughout the region and has participated in numerous research trials exploring early detection and treatment of cardiovascular diseases. He is a founding member of the Mississippi Health Care Alliance, an organization which has developed the nation’s first statewide system of care for both heart attack and stroke. He is also board certified by the American Board of Internal Medicine in cardiovascular disease, internal medicine and interventional cardiology.

      About Change Healthcare

      Change Healthcare is a leading independent healthcare technology company, focused on insights, innovation and accelerating the transformation of the healthcare system through the power of the Change Healthcare platform. We provide data and analytics-driven solutions to improve clinical, financial, administrative, and patient engagement outcomes in the U.S. healthcare system.

      Sponsored Videos View all 46 items

      Cardiovascular Ultrasound | July 20, 2022

      Enhanced features on the Philips EPIQ CVx ultrasound system provide a next level photorealistic 3D rendering, making it easy for users to interpret what they are seeing. The TrueVue feature enhances the sense of depth and space, producing images that appear natural and realistic to the human eye.  

      Watch the video to check out how TrueVue can help improve views of LAA and MV morphology. 

      Cardiovascular Ultrasound | July 07, 2022

      Automated features on the Philips EPIQ CVx cardiology ultrasound system are helping to bring consistency and speed to every echo exam. The AI-empowered algorithm delivers fast and consistent measurements – in half the time of manual methods.*  

      Watch the video to see how you can put “smart”  to work with the latest AI-powered quantification tools. 

      *External study with external sonographers comparing the results of 18 exams with and without AutoMeasure

      Cardiovascular Ultrasound | June 14, 2022

      The X5-1c transducer from Philips provides enhanced clinical information in transthoracic imaging over a standard phased array transducer. When combined with nSIGHT Plus image formation on the EPIQ CVx cardiology ultrasound system, the X5-1c transducer enables image quality rarely seen from a transthoracic transducer. 

      Watch the video to learn about the benefits which may include decreased exam time due to faster access to echo windows, increased confidence in quantification results and more. 

      Cardiovascular Ultrasound | May 31, 2022

      Philips recently announced an update to their flagship EPIQ CVx premium cardiology ultrasound system. Watch the video to learn about the latest features including the next-generation nSIGHT Plus imaging architecture system that leverages both hardware and software to support sophisticated image formation and enhanced image quality.

      Conference Coverage View all 467 items

      Cardiovascular Clinical Studies | July 30, 2024

      As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

      As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

      His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

      Related content:

      DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

      DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

       

      HIMSS | July 24, 2024

      Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

      Find more HIMSS24 conference coverage here

      A New Partnership for Growth

      Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

      Exciting New Features at HIMSS24

      At HIMSS2024, with this new collaboration comes new features, including:

      Related content:

      Find more HIMSS24 conference coverage here

      HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

      Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      Information Technology | May 17, 2023

      HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

      Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

      Find more HIMSS23 coverage here

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

       

      Related Digital Transformation Content:

      Robocath Launches New Robotic Platform R-One+

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      New ACC President Defines Priorities for Year Ahead

      Health That Connects + Tech That Cares at HIMSS 2023

      ACC22: Transforming Cardiovascular Care

       

       

      Information Technology | May 11, 2023

      Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

      Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

      Find more HIMSS23 coverage here

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      Related Digital Transformation Content:

      Robocath Launches New Robotic Platform R-One+

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      New ACC President Defines Priorities for Year Ahead

      Health That Connects + Tech That Cares at HIMSS 2023

      ACC22: Transforming Cardiovascular Care

      Cath Lab View all 316 items

      Cardiovascular Clinical Studies | July 30, 2024

      As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

      As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

      His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

      Related content:

      DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

      DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

       

      HIMSS | July 24, 2024

      Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

      Find more HIMSS24 conference coverage here

      A New Partnership for Growth

      Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

      Exciting New Features at HIMSS24

      At HIMSS2024, with this new collaboration comes new features, including:

      Related content:

      Find more HIMSS24 conference coverage here

      HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

      Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      Information Technology | May 17, 2023

      HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

      Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

      Find more HIMSS23 coverage here

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

       

      Related Digital Transformation Content:

      Robocath Launches New Robotic Platform R-One+

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      New ACC President Defines Priorities for Year Ahead

      Health That Connects + Tech That Cares at HIMSS 2023

      ACC22: Transforming Cardiovascular Care

       

       

      Information Technology | May 11, 2023

      Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

      Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

      Find more HIMSS23 coverage here

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      Related Digital Transformation Content:

      Robocath Launches New Robotic Platform R-One+

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      New ACC President Defines Priorities for Year Ahead

      Health That Connects + Tech That Cares at HIMSS 2023

      ACC22: Transforming Cardiovascular Care

      Cardiac Imaging View all 289 items

      Cardiovascular Clinical Studies | July 30, 2024

      As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

      As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

      His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

      Related content:

      DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

      DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

       

      HIMSS | July 24, 2024

      Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

      Find more HIMSS24 conference coverage here

      A New Partnership for Growth

      Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

      Exciting New Features at HIMSS24

      At HIMSS2024, with this new collaboration comes new features, including:

      Related content:

      Find more HIMSS24 conference coverage here

      HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

      Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      Information Technology | May 17, 2023

      HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

      Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

      Find more HIMSS23 coverage here

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

       

      Related Digital Transformation Content:

      Robocath Launches New Robotic Platform R-One+

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      New ACC President Defines Priorities for Year Ahead

      Health That Connects + Tech That Cares at HIMSS 2023

      ACC22: Transforming Cardiovascular Care

       

       

      Information Technology | May 11, 2023

      Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

      Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

      Find more HIMSS23 coverage here

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      Related Digital Transformation Content:

      Robocath Launches New Robotic Platform R-One+

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      New ACC President Defines Priorities for Year Ahead

      Health That Connects + Tech That Cares at HIMSS 2023

      ACC22: Transforming Cardiovascular Care

      Cardiac Diagnostics View all 78 items

      Cardiovascular Clinical Studies | July 30, 2024

      As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

      As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

      His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

      Related content:

      DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

      DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

       

      HIMSS | July 24, 2024

      Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

      Find more HIMSS24 conference coverage here

      A New Partnership for Growth

      Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

      Exciting New Features at HIMSS24

      At HIMSS2024, with this new collaboration comes new features, including:

      Related content:

      Find more HIMSS24 conference coverage here

      HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

      Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      Information Technology | May 17, 2023

      HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

      Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

      Find more HIMSS23 coverage here

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

       

      Related Digital Transformation Content:

      Robocath Launches New Robotic Platform R-One+

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      New ACC President Defines Priorities for Year Ahead

      Health That Connects + Tech That Cares at HIMSS 2023

      ACC22: Transforming Cardiovascular Care

       

       

      Information Technology | May 11, 2023

      Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

      Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

      Find more HIMSS23 coverage here

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      Related Digital Transformation Content:

      Robocath Launches New Robotic Platform R-One+

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      New ACC President Defines Priorities for Year Ahead

      Health That Connects + Tech That Cares at HIMSS 2023

      ACC22: Transforming Cardiovascular Care

      EP Lab View all 83 items

      Cardiovascular Clinical Studies | July 30, 2024

      As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

      As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

      His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

      Related content:

      DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

      DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

       

      HIMSS | July 24, 2024

      Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

      Find more HIMSS24 conference coverage here

      A New Partnership for Growth

      Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

      Exciting New Features at HIMSS24

      At HIMSS2024, with this new collaboration comes new features, including:

      Related content:

      Find more HIMSS24 conference coverage here

      HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

      Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      Information Technology | May 17, 2023

      HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

      Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

      Find more HIMSS23 coverage here

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

       

      Related Digital Transformation Content:

      Robocath Launches New Robotic Platform R-One+

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      New ACC President Defines Priorities for Year Ahead

      Health That Connects + Tech That Cares at HIMSS 2023

      ACC22: Transforming Cardiovascular Care

       

       

      Information Technology | May 11, 2023

      Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

      Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

      Find more HIMSS23 coverage here

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      Related Digital Transformation Content:

      Robocath Launches New Robotic Platform R-One+

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      New ACC President Defines Priorities for Year Ahead

      Health That Connects + Tech That Cares at HIMSS 2023

      ACC22: Transforming Cardiovascular Care

      Information Technology View all 177 items

      Cardiovascular Clinical Studies | July 30, 2024

      As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

      As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

      His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

      Related content:

      DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

      DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

       

      HIMSS | July 24, 2024

      Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

      Find more HIMSS24 conference coverage here

      A New Partnership for Growth

      Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

      Exciting New Features at HIMSS24

      At HIMSS2024, with this new collaboration comes new features, including:

      Related content:

      Find more HIMSS24 conference coverage here

      HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

      Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      Information Technology | May 17, 2023

      HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

      Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

      Find more HIMSS23 coverage here

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

       

      Related Digital Transformation Content:

      Robocath Launches New Robotic Platform R-One+

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      New ACC President Defines Priorities for Year Ahead

      Health That Connects + Tech That Cares at HIMSS 2023

      ACC22: Transforming Cardiovascular Care

       

       

      Information Technology | May 11, 2023

      Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

      Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

      Find more HIMSS23 coverage here

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      Related Digital Transformation Content:

      Robocath Launches New Robotic Platform R-One+

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      New ACC President Defines Priorities for Year Ahead

      Health That Connects + Tech That Cares at HIMSS 2023

      ACC22: Transforming Cardiovascular Care

      Todd Villines explains how AI is being used to automate CT calcium scoring
      Video Player is loading.
      Current Time 0:00
      Duration 5:24
      Loaded: 0%
      Stream Type LIVE
      Remaining Time 5:24
       
      1x
        • Chapters
        • descriptions off, selected
        • captions off, selected
        • en (Main), selected

        Todd Villines, M.D., FACC, FAHA, MSCCT, explains how artificial intelligence (AI) might be used in the near future to automatically calculate CT calcium scoring and radiomic feature assessments. This was a key take away during the Society of Cardiovascular Computed Tomography (SCCT) 2020 virtual meeting. 

        Villines is the Julian Ruffin Beckwith Professor of Medicine, Division of Cardiovascular Medicine, University of Virginia, editor-in-chief of the Journal of Cardiovascular CT (JCCT),  and SCCT past-president.

        AI is already commercially used to improve CT image reconstruction to increase the diagnostic quality of the images, especially from low-dose scans. AI is now being applied to automate time-consuming tasks in CT image reads, such as manually calculated calcium scores and automated contouring and quantification of anatomy and function of the heart.

        Another area that is seeing a lot of research in in radiomics, where AI is being used to sift through thousands of CT scans to look for subtle imaging traits that may indicate the early development or worsening of disease. These subtle changes may not be evident to radiologists reading the scans, but AI software can identify similarities in patients as a trend and alert researchers to look at that specific trait as a potential imaging biomarker.

         

        Other Key Trends and Technology at SCCT:

        Top 9 Cardiovascular CT Studies in Past Year 

        VIDEO: Photon Counting Detectors Will be the Next Major Advance in Computed Tomography

        VIDEO: Increased Use of Cardiac CT During the COVID-19 Pandemic

        VIDEO: Key Cardiac CT Papers Presented at SCCT 2020

        Low-attenuation Coronary Plaque Burden May Become Next Big Cardiac Risk Assessment

        Impact of Cardiac CT During COVID-19

        VIDEO: Artificial Intelligence to Automate CT Calcium Scoring and Radiomics

         

        Recent Videos View all 660 items

        January 30, 2025

        On July 16, 2024, Diagnostic and Interventional Cardiology presented a webinar on "Maximizing Structural Heart Workflows: Harnessing the Power of CVIS and AI." 

        During the webinar, Omer Schalit–Cohen, chief product officer at Optum’s Healthcare Enterprising Imaging business unit, addressed optimizing workflow and efficiencies in the cardiovascular imaging department.  In the presentation, Cohen examines how you can harness the power of the CVIS and AI technologies to enhance structural heart workflow in the EP lab and ultrasound procedures.

        Schalit–Cohen is the chief product officer at Optum’s Healthcare Enterprising Imaging business unit. With more than 20 years of experience in innovation, he is an expert in the Imaging’s department complex workflows and has been instrumental in driving market leading solutions that have significantly enhanced patient care and department’s efficiency. as well as customer satisfaction.
         

        Company Profile

        The webinar is sponsored by Optum, a leading information and technology-enabled health services business dedicated to helping make the health system work better for everyone. With more than 215,000 people worldwide, Optum delivers intelligent, integrated solutions that help to modernize the health system and improve overall population health. Optum is part of UnitedHealth Group.

        For more information, visit optum.com.

        January 07, 2025

        On Jan. 10, 2024, Diagnostic and Interventional Cardiology presented a webinar on "Contrast Management in Modern PCI." 

        Dr. Aditya Sharma, MD, MBA, FACC, FSCAI, an interventional cardiologist from Wellspan Health in Central Pennsylvania was the presenter. The webinar is sponsored by ACIST Medical Systems.

        In the cardiac cath lab, the use of iodinated contrast in both diagnostic and PCI procedures is commonplace. The effects of iodinated contrast on renal function have been known and researched. However, conversations are ongoing around best practices and standards of care regarding contrast management and treatment for those with higher risk factors, like compromised renal function. Participate in this webinar to gain insight on the topic of contrast-induced kidney injury and how one could approach contrast management in modern PCI with use of the ACIST CVi Contrast Delivery System.

        Learning Objectives

        * Understand basic mechanisms of contrast induced kidney injury.
        * Determine incidence of disease along with long term patient and economic implications.
        * Review risk factors determining higher risk populations.
        * Evaluate device strategy in modern era to mitigate risk and promote procedural efficiency and safety.
        * Case review of use of the ACIST CVi Contrast Delivery System in high risk patient. 

        Dr. Aditya Sharma
        Dr Aditya Sharma

        Dr. Sharma is board certified in internal medicine, cardiovascular disease, and interventional cardiology, having completed both residency and fellowship programs at George Washington University - School of Medicine and Hospital. He chose a career in medicine to be able to help others while being able to continuously enrich his skills and apply learned scientific knowledge.

        About ACIST

        Physicians worldwide rely on our diagnostic technologies to give them the power to visualize, assess and inform patient treatment. ACIST informs interventional decisions during peripheral, cardiovascular disease and structural heart procedures. Economic decision-makers appreciate our ability to demonstrate the value of therapeutic intervention.

        January 01, 2025

        Preventing contrast induced nephropathy and managing patients with chronic kidney disease remain major challenges in the cardiac catheterization lab. In recent years, contrast supply shortages have presented a new challenge to care delivery. When considering these challenges, and as quality metrics in our labs face more scrutiny, there are existing technologies and best practices such as a variable rate contrast delivery systems and HD IVUS that can be used to manage workflow and improve patient outcomes.

        The ACC Interventional Council’s recent statement recommending that intracoronary imaging be a routine part of clinical practice further reinforces the need for adoption of intracoronary. Using a case-based approach, the faculty will demonstrate how to use the ACIST CVi contrast delivery system, HDi high definition IVUS and diagnostic and post-PCI physiologic assessment to reduce contrast usage, improve AKI rates and deliver optimized patient outcomes.

        Learning Objectives

        By the end of this webinar, participants will understand that high-quality care starts at the point of education and can transform cardiovascular imaging. Attendees will see how optimized workflows can improve quality and will be able to:

        • To understand the benefits of implementing a variable rate contrast delivery system in the cath lab.

        • To understand the clinical benefits of HD IVUS utilization and how to implement a standardized workflow for effective use.

        • To understand how HD IVUS and physiologic testing can be used to improve patient outcomes and reduce contrast utilization.

        Featured Speakers

        headshot

        Dr. Matheen A. Khuddus, Director of Cardiovascular Research/Director of the Cardiac Catheterization Lab, HCA Florida North Florida Hospital and the Cardiac & Vascular Institute, Gainesville, Fla.

        Dr. Khuddus is an interventional cardiologist who currently serves as the Director of Cardiovascular Research and the Director of the Cardiac Catheterization Lab as well as a National Physician Director for HCA Healthcare. He is a fellow of the ACC and SCAI.  He is board certified in Cardiovascular Medicine, Interventional Cardiology, and Internal Medicine.  He is also an AHSCP Clinical Hypertension Specialist.



        headshot

        Dr. Darshan Doshi, Director of Complex Coronary Artery Disease, Massachusetts General Hospital, Boston, Mass.

        Dr. Doshi is an interventional cardiologist who specializes in complex coronary intervention, specifically chronic total occlusions, surgical turndowns, ultralow and zero contrast stenting procedures, and treatment of recurrent stent blockages. He is the Director of Complex Coronary Artery Disease at MGH. He is board certified in Cardiovascular Medicine and Interventional Cardiology.

        About ACIST

        Physicians worldwide rely on our diagnostic technologies to give them the power to visualize, assess and inform patient treatment. ACIST informs interventional decisions during peripheral, cardiovascular disease and structural heart procedures. Economic decision-makers appreciate our ability to demonstrate the value of therapeutic intervention.

        January 24, 2025

        Behavioral science is being applied in unique ways for enterprise-imaging product design.

        Behavioral science is the study of human behavior. It’s a mix of psychology, sociology, social and cultural anthropology, and economics. Using a data-driven, human-centered approach, behavioral science helps uncover what people have done in the past and tries to predict — and often change — how they’ll behave in the future.

        In this webinar, leading healthcare experts will discuss how observation, interviews, and experimentation can help the industry form a better understanding of current customer needs and pain points within cardiovascular imaging. Having clinicians involved in the product-design process has led to the complete rearchitecting of a next-generation hemodynamics solution.

        Using a real-world scenario, we’ll share a clinician’s experience working with behavioral science and product-development teams, provide an understanding of how they’re using hemodynamics today, and get their thoughts on the future of imaging and hemodynamics.

        By listening to key stakeholders, new features can be brought to market that will have a notable impact on the way health systems operate. By building better products, we can help improve patient outcomes and ultimately transform the healthcare industry — one behavior at a time.

        Learning Objectives

        • How a next-generation hemodynamics system has implemented 19 user-centric concepts and undergone iterative testing with healthcare providers.

        • How physicians, technicians, nurses and administrators are providing their expertise to bring new features to market that will have a notable impact on the way health systems operate.

        • What a next-generation hemodynamics system can do to keep pace with new technology innovations in cardiovascular care and increasing clinical demands.

        Featured Speakers

        James Stinnett

        James Stinnett, Behavioral Scientist, Change Healthcare

        James Stinnett is an experienced researcher with a background in product, UX, and behavioral science. He joined Change Healthcare three years ago and is currently a researcher on the behavioral science team.

        Dr. Barry Bertolet

        Dr. Barry Bertolet, Interventional Cardiologist and Director of Cardiac Catheterization Laboratory, North Mississippi Medical Center

        Dr. Barry Bertolet champions the education of physicians and patients throughout the region and has participated in numerous research trials exploring early detection and treatment of cardiovascular diseases. He is a founding member of the Mississippi Health Care Alliance, an organization which has developed the nation’s first statewide system of care for both heart attack and stroke. He is also board certified by the American Board of Internal Medicine in cardiovascular disease, internal medicine and interventional cardiology.

        About Change Healthcare

        Change Healthcare is a leading independent healthcare technology company, focused on insights, innovation and accelerating the transformation of the healthcare system through the power of the Change Healthcare platform. We provide data and analytics-driven solutions to improve clinical, financial, administrative, and patient engagement outcomes in the U.S. healthcare system.

        Sponsored Videos View all 46 items

        Cardiovascular Ultrasound | July 20, 2022

        Enhanced features on the Philips EPIQ CVx ultrasound system provide a next level photorealistic 3D rendering, making it easy for users to interpret what they are seeing. The TrueVue feature enhances the sense of depth and space, producing images that appear natural and realistic to the human eye.  

        Watch the video to check out how TrueVue can help improve views of LAA and MV morphology. 

        Cardiovascular Ultrasound | July 07, 2022

        Automated features on the Philips EPIQ CVx cardiology ultrasound system are helping to bring consistency and speed to every echo exam. The AI-empowered algorithm delivers fast and consistent measurements – in half the time of manual methods.*  

        Watch the video to see how you can put “smart”  to work with the latest AI-powered quantification tools. 

        *External study with external sonographers comparing the results of 18 exams with and without AutoMeasure

        Cardiovascular Ultrasound | June 14, 2022

        The X5-1c transducer from Philips provides enhanced clinical information in transthoracic imaging over a standard phased array transducer. When combined with nSIGHT Plus image formation on the EPIQ CVx cardiology ultrasound system, the X5-1c transducer enables image quality rarely seen from a transthoracic transducer. 

        Watch the video to learn about the benefits which may include decreased exam time due to faster access to echo windows, increased confidence in quantification results and more. 

        Cardiovascular Ultrasound | May 31, 2022

        Philips recently announced an update to their flagship EPIQ CVx premium cardiology ultrasound system. Watch the video to learn about the latest features including the next-generation nSIGHT Plus imaging architecture system that leverages both hardware and software to support sophisticated image formation and enhanced image quality.

        Conference Coverage View all 467 items

        Cardiovascular Clinical Studies | July 30, 2024

        As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

        As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

        His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

        Related content:

        DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

        DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

         

        HIMSS | July 24, 2024

        Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

        Find more HIMSS24 conference coverage here

        A New Partnership for Growth

        Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

        Exciting New Features at HIMSS24

        At HIMSS2024, with this new collaboration comes new features, including:

        Related content:

        Find more HIMSS24 conference coverage here

        HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

        Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

        VIDEO: Using Maturity Models to Measure Digital Health

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        Information Technology | May 17, 2023

        HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

        Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

        Find more HIMSS23 coverage here

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

         

        Related Digital Transformation Content:

        Robocath Launches New Robotic Platform R-One+

        VIDEO: Using Maturity Models to Measure Digital Health

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        New ACC President Defines Priorities for Year Ahead

        Health That Connects + Tech That Cares at HIMSS 2023

        ACC22: Transforming Cardiovascular Care

         

         

        Information Technology | May 11, 2023

        Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

        Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

        Find more HIMSS23 coverage here

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        Related Digital Transformation Content:

        Robocath Launches New Robotic Platform R-One+

        VIDEO: Using Maturity Models to Measure Digital Health

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        New ACC President Defines Priorities for Year Ahead

        Health That Connects + Tech That Cares at HIMSS 2023

        ACC22: Transforming Cardiovascular Care

        Cath Lab View all 316 items

        Cardiovascular Clinical Studies | July 30, 2024

        As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

        As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

        His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

        Related content:

        DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

        DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

         

        HIMSS | July 24, 2024

        Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

        Find more HIMSS24 conference coverage here

        A New Partnership for Growth

        Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

        Exciting New Features at HIMSS24

        At HIMSS2024, with this new collaboration comes new features, including:

        Related content:

        Find more HIMSS24 conference coverage here

        HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

        Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

        VIDEO: Using Maturity Models to Measure Digital Health

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        Information Technology | May 17, 2023

        HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

        Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

        Find more HIMSS23 coverage here

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

         

        Related Digital Transformation Content:

        Robocath Launches New Robotic Platform R-One+

        VIDEO: Using Maturity Models to Measure Digital Health

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        New ACC President Defines Priorities for Year Ahead

        Health That Connects + Tech That Cares at HIMSS 2023

        ACC22: Transforming Cardiovascular Care

         

         

        Information Technology | May 11, 2023

        Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

        Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

        Find more HIMSS23 coverage here

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        Related Digital Transformation Content:

        Robocath Launches New Robotic Platform R-One+

        VIDEO: Using Maturity Models to Measure Digital Health

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        New ACC President Defines Priorities for Year Ahead

        Health That Connects + Tech That Cares at HIMSS 2023

        ACC22: Transforming Cardiovascular Care

        Cardiac Imaging View all 289 items

        Cardiovascular Clinical Studies | July 30, 2024

        As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

        As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

        His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

        Related content:

        DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

        DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

         

        HIMSS | July 24, 2024

        Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

        Find more HIMSS24 conference coverage here

        A New Partnership for Growth

        Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

        Exciting New Features at HIMSS24

        At HIMSS2024, with this new collaboration comes new features, including:

        Related content:

        Find more HIMSS24 conference coverage here

        HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

        Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

        VIDEO: Using Maturity Models to Measure Digital Health

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        Information Technology | May 17, 2023

        HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

        Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

        Find more HIMSS23 coverage here

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

         

        Related Digital Transformation Content:

        Robocath Launches New Robotic Platform R-One+

        VIDEO: Using Maturity Models to Measure Digital Health

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        New ACC President Defines Priorities for Year Ahead

        Health That Connects + Tech That Cares at HIMSS 2023

        ACC22: Transforming Cardiovascular Care

         

         

        Information Technology | May 11, 2023

        Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

        Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

        Find more HIMSS23 coverage here

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        Related Digital Transformation Content:

        Robocath Launches New Robotic Platform R-One+

        VIDEO: Using Maturity Models to Measure Digital Health

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        New ACC President Defines Priorities for Year Ahead

        Health That Connects + Tech That Cares at HIMSS 2023

        ACC22: Transforming Cardiovascular Care

        Cardiac Diagnostics View all 78 items

        Cardiovascular Clinical Studies | July 30, 2024

        As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

        As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

        His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

        Related content:

        DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

        DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

         

        HIMSS | July 24, 2024

        Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

        Find more HIMSS24 conference coverage here

        A New Partnership for Growth

        Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

        Exciting New Features at HIMSS24

        At HIMSS2024, with this new collaboration comes new features, including:

        Related content:

        Find more HIMSS24 conference coverage here

        HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

        Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

        VIDEO: Using Maturity Models to Measure Digital Health

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        Information Technology | May 17, 2023

        HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

        Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

        Find more HIMSS23 coverage here

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

         

        Related Digital Transformation Content:

        Robocath Launches New Robotic Platform R-One+

        VIDEO: Using Maturity Models to Measure Digital Health

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        New ACC President Defines Priorities for Year Ahead

        Health That Connects + Tech That Cares at HIMSS 2023

        ACC22: Transforming Cardiovascular Care

         

         

        Information Technology | May 11, 2023

        Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

        Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

        Find more HIMSS23 coverage here

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        Related Digital Transformation Content:

        Robocath Launches New Robotic Platform R-One+

        VIDEO: Using Maturity Models to Measure Digital Health

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        New ACC President Defines Priorities for Year Ahead

        Health That Connects + Tech That Cares at HIMSS 2023

        ACC22: Transforming Cardiovascular Care

        EP Lab View all 83 items

        Cardiovascular Clinical Studies | July 30, 2024

        As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

        As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

        His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

        Related content:

        DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

        DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

         

        HIMSS | July 24, 2024

        Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

        Find more HIMSS24 conference coverage here

        A New Partnership for Growth

        Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

        Exciting New Features at HIMSS24

        At HIMSS2024, with this new collaboration comes new features, including:

        Related content:

        Find more HIMSS24 conference coverage here

        HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

        Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

        VIDEO: Using Maturity Models to Measure Digital Health

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        Information Technology | May 17, 2023

        HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

        Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

        Find more HIMSS23 coverage here

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

         

        Related Digital Transformation Content:

        Robocath Launches New Robotic Platform R-One+

        VIDEO: Using Maturity Models to Measure Digital Health

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        New ACC President Defines Priorities for Year Ahead

        Health That Connects + Tech That Cares at HIMSS 2023

        ACC22: Transforming Cardiovascular Care

         

         

        Information Technology | May 11, 2023

        Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

        Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

        Find more HIMSS23 coverage here

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        Related Digital Transformation Content:

        Robocath Launches New Robotic Platform R-One+

        VIDEO: Using Maturity Models to Measure Digital Health

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        New ACC President Defines Priorities for Year Ahead

        Health That Connects + Tech That Cares at HIMSS 2023

        ACC22: Transforming Cardiovascular Care

        Information Technology View all 177 items

        Cardiovascular Clinical Studies | July 30, 2024

        As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

        As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

        His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

        Related content:

        DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

        DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

         

        HIMSS | July 24, 2024

        Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

        Find more HIMSS24 conference coverage here

        A New Partnership for Growth

        Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

        Exciting New Features at HIMSS24

        At HIMSS2024, with this new collaboration comes new features, including:

        Related content:

        Find more HIMSS24 conference coverage here

        HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

        Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

        VIDEO: Using Maturity Models to Measure Digital Health

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        Information Technology | May 17, 2023

        HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

        Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

        Find more HIMSS23 coverage here

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

         

        Related Digital Transformation Content:

        Robocath Launches New Robotic Platform R-One+

        VIDEO: Using Maturity Models to Measure Digital Health

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        New ACC President Defines Priorities for Year Ahead

        Health That Connects + Tech That Cares at HIMSS 2023

        ACC22: Transforming Cardiovascular Care

         

         

        Information Technology | May 11, 2023

        Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

        Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

        Find more HIMSS23 coverage here

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        Related Digital Transformation Content:

        Robocath Launches New Robotic Platform R-One+

        VIDEO: Using Maturity Models to Measure Digital Health

        VIDEO: Moving Digital Transformation Forward in Healthcare

        VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

        VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

        VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

        New ACC President Defines Priorities for Year Ahead

        Health That Connects + Tech That Cares at HIMSS 2023

        ACC22: Transforming Cardiovascular Care

        August 12, 2020 — A national survey conducted by the patient advocacy group Heart-Valve-Surgery.com with support by Medtronic, found that nearly half (49 percent) of heart valve patients said returning to active living is a key factor in their treatment decision. The survey of more than 3,400 heart valve patients and caregivers uncovered real-world insights around managing heart valve disease, from diagnosis through treatment and beyond. The survey findings help kick off a new Active Living Awareness Initiative.

        August 12, 2020 — GE focused on the latest innovations from the handheld ultrasound, Vscan Extend system, which is about the size of a cellular phone. Advances include the LVivo EF app from DiA Imaging Analysis for AI-based automated ejection fraction analysis.

        Todd Villines Explains new CT photon counting detector technology
        Video Player is loading.
        Current Time 0:00
        Duration 4:27
        Loaded: 0%
        Stream Type LIVE
        Remaining Time 4:27
         
        1x
          • Chapters
          • descriptions off, selected
          • captions off, selected
          • en (Main), selected

          Todd Villines, M.D., FACC, FAHA, MSCCT, said photon counting CT detectors were a key new technology discussed at the Society of Cardiovascular Computed Tomography (SCCT) 2020 virtual meeting. He said the technology will likely replace conventional CT detectors in the next decade.

          These new detectors also can take a single scan and bin the various energies to reconstruct a range of mono-energtic scan renderings similar to dual-energy CT, but on a wider spectrum of kV levels. This spectral aspect of photon counting also allows material decomposition based on the chemical elements that make up various materials in the scan, including calcium and metals that make up stents, orthopedic implants and replacement heart valves. This enables easier, automated removal of metal blooming artifacts and the ability to clearly image inside calcified arteries.

          Villines is the Julian Ruffin Beckwith Professor of Medicine, Division of Cardiovascular Medicine, University of Virginia, editor-in-chief of the Journal of Cardiovascular CT (JCCT),  and SCCT past-president.

           

          Other Key Trends and Technology at SCCT:

          Top 9 Cardiovascular CT Studies in Past Year 

          VIDEO: Increased Use of Cardiac CT During the COVID-19 Pandemic

          VIDEO: Coronary Plaque Quantification Will Become Major Risk Assessment

          VIDEO: Key Cardiac CT Papers Presented at SCCT 2020

          VIDEO: Artificial Intelligence to Automate CT Calcium Scoring and Radiomics

          Low-attenuation Coronary Plaque Burden May Become Next Big Cardiac Risk Assessment

          Impact of Cardiac CT During COVID-19



           

          Recent Videos View all 660 items

          January 30, 2025

          On July 16, 2024, Diagnostic and Interventional Cardiology presented a webinar on "Maximizing Structural Heart Workflows: Harnessing the Power of CVIS and AI." 

          During the webinar, Omer Schalit–Cohen, chief product officer at Optum’s Healthcare Enterprising Imaging business unit, addressed optimizing workflow and efficiencies in the cardiovascular imaging department.  In the presentation, Cohen examines how you can harness the power of the CVIS and AI technologies to enhance structural heart workflow in the EP lab and ultrasound procedures.

          Schalit–Cohen is the chief product officer at Optum’s Healthcare Enterprising Imaging business unit. With more than 20 years of experience in innovation, he is an expert in the Imaging’s department complex workflows and has been instrumental in driving market leading solutions that have significantly enhanced patient care and department’s efficiency. as well as customer satisfaction.
           

          Company Profile

          The webinar is sponsored by Optum, a leading information and technology-enabled health services business dedicated to helping make the health system work better for everyone. With more than 215,000 people worldwide, Optum delivers intelligent, integrated solutions that help to modernize the health system and improve overall population health. Optum is part of UnitedHealth Group.

          For more information, visit optum.com.

          January 07, 2025

          On Jan. 10, 2024, Diagnostic and Interventional Cardiology presented a webinar on "Contrast Management in Modern PCI." 

          Dr. Aditya Sharma, MD, MBA, FACC, FSCAI, an interventional cardiologist from Wellspan Health in Central Pennsylvania was the presenter. The webinar is sponsored by ACIST Medical Systems.

          In the cardiac cath lab, the use of iodinated contrast in both diagnostic and PCI procedures is commonplace. The effects of iodinated contrast on renal function have been known and researched. However, conversations are ongoing around best practices and standards of care regarding contrast management and treatment for those with higher risk factors, like compromised renal function. Participate in this webinar to gain insight on the topic of contrast-induced kidney injury and how one could approach contrast management in modern PCI with use of the ACIST CVi Contrast Delivery System.

          Learning Objectives

          * Understand basic mechanisms of contrast induced kidney injury.
          * Determine incidence of disease along with long term patient and economic implications.
          * Review risk factors determining higher risk populations.
          * Evaluate device strategy in modern era to mitigate risk and promote procedural efficiency and safety.
          * Case review of use of the ACIST CVi Contrast Delivery System in high risk patient. 

          Dr. Aditya Sharma
          Dr Aditya Sharma

          Dr. Sharma is board certified in internal medicine, cardiovascular disease, and interventional cardiology, having completed both residency and fellowship programs at George Washington University - School of Medicine and Hospital. He chose a career in medicine to be able to help others while being able to continuously enrich his skills and apply learned scientific knowledge.

          About ACIST

          Physicians worldwide rely on our diagnostic technologies to give them the power to visualize, assess and inform patient treatment. ACIST informs interventional decisions during peripheral, cardiovascular disease and structural heart procedures. Economic decision-makers appreciate our ability to demonstrate the value of therapeutic intervention.

          January 01, 2025

          Preventing contrast induced nephropathy and managing patients with chronic kidney disease remain major challenges in the cardiac catheterization lab. In recent years, contrast supply shortages have presented a new challenge to care delivery. When considering these challenges, and as quality metrics in our labs face more scrutiny, there are existing technologies and best practices such as a variable rate contrast delivery systems and HD IVUS that can be used to manage workflow and improve patient outcomes.

          The ACC Interventional Council’s recent statement recommending that intracoronary imaging be a routine part of clinical practice further reinforces the need for adoption of intracoronary. Using a case-based approach, the faculty will demonstrate how to use the ACIST CVi contrast delivery system, HDi high definition IVUS and diagnostic and post-PCI physiologic assessment to reduce contrast usage, improve AKI rates and deliver optimized patient outcomes.

          Learning Objectives

          By the end of this webinar, participants will understand that high-quality care starts at the point of education and can transform cardiovascular imaging. Attendees will see how optimized workflows can improve quality and will be able to:

          • To understand the benefits of implementing a variable rate contrast delivery system in the cath lab.

          • To understand the clinical benefits of HD IVUS utilization and how to implement a standardized workflow for effective use.

          • To understand how HD IVUS and physiologic testing can be used to improve patient outcomes and reduce contrast utilization.

          Featured Speakers

          headshot

          Dr. Matheen A. Khuddus, Director of Cardiovascular Research/Director of the Cardiac Catheterization Lab, HCA Florida North Florida Hospital and the Cardiac & Vascular Institute, Gainesville, Fla.

          Dr. Khuddus is an interventional cardiologist who currently serves as the Director of Cardiovascular Research and the Director of the Cardiac Catheterization Lab as well as a National Physician Director for HCA Healthcare. He is a fellow of the ACC and SCAI.  He is board certified in Cardiovascular Medicine, Interventional Cardiology, and Internal Medicine.  He is also an AHSCP Clinical Hypertension Specialist.



          headshot

          Dr. Darshan Doshi, Director of Complex Coronary Artery Disease, Massachusetts General Hospital, Boston, Mass.

          Dr. Doshi is an interventional cardiologist who specializes in complex coronary intervention, specifically chronic total occlusions, surgical turndowns, ultralow and zero contrast stenting procedures, and treatment of recurrent stent blockages. He is the Director of Complex Coronary Artery Disease at MGH. He is board certified in Cardiovascular Medicine and Interventional Cardiology.

          About ACIST

          Physicians worldwide rely on our diagnostic technologies to give them the power to visualize, assess and inform patient treatment. ACIST informs interventional decisions during peripheral, cardiovascular disease and structural heart procedures. Economic decision-makers appreciate our ability to demonstrate the value of therapeutic intervention.

          January 24, 2025

          Behavioral science is being applied in unique ways for enterprise-imaging product design.

          Behavioral science is the study of human behavior. It’s a mix of psychology, sociology, social and cultural anthropology, and economics. Using a data-driven, human-centered approach, behavioral science helps uncover what people have done in the past and tries to predict — and often change — how they’ll behave in the future.

          In this webinar, leading healthcare experts will discuss how observation, interviews, and experimentation can help the industry form a better understanding of current customer needs and pain points within cardiovascular imaging. Having clinicians involved in the product-design process has led to the complete rearchitecting of a next-generation hemodynamics solution.

          Using a real-world scenario, we’ll share a clinician’s experience working with behavioral science and product-development teams, provide an understanding of how they’re using hemodynamics today, and get their thoughts on the future of imaging and hemodynamics.

          By listening to key stakeholders, new features can be brought to market that will have a notable impact on the way health systems operate. By building better products, we can help improve patient outcomes and ultimately transform the healthcare industry — one behavior at a time.

          Learning Objectives

          • How a next-generation hemodynamics system has implemented 19 user-centric concepts and undergone iterative testing with healthcare providers.

          • How physicians, technicians, nurses and administrators are providing their expertise to bring new features to market that will have a notable impact on the way health systems operate.

          • What a next-generation hemodynamics system can do to keep pace with new technology innovations in cardiovascular care and increasing clinical demands.

          Featured Speakers

          James Stinnett

          James Stinnett, Behavioral Scientist, Change Healthcare

          James Stinnett is an experienced researcher with a background in product, UX, and behavioral science. He joined Change Healthcare three years ago and is currently a researcher on the behavioral science team.

          Dr. Barry Bertolet

          Dr. Barry Bertolet, Interventional Cardiologist and Director of Cardiac Catheterization Laboratory, North Mississippi Medical Center

          Dr. Barry Bertolet champions the education of physicians and patients throughout the region and has participated in numerous research trials exploring early detection and treatment of cardiovascular diseases. He is a founding member of the Mississippi Health Care Alliance, an organization which has developed the nation’s first statewide system of care for both heart attack and stroke. He is also board certified by the American Board of Internal Medicine in cardiovascular disease, internal medicine and interventional cardiology.

          About Change Healthcare

          Change Healthcare is a leading independent healthcare technology company, focused on insights, innovation and accelerating the transformation of the healthcare system through the power of the Change Healthcare platform. We provide data and analytics-driven solutions to improve clinical, financial, administrative, and patient engagement outcomes in the U.S. healthcare system.

          Sponsored Videos View all 46 items

          Cardiovascular Ultrasound | July 20, 2022

          Enhanced features on the Philips EPIQ CVx ultrasound system provide a next level photorealistic 3D rendering, making it easy for users to interpret what they are seeing. The TrueVue feature enhances the sense of depth and space, producing images that appear natural and realistic to the human eye.  

          Watch the video to check out how TrueVue can help improve views of LAA and MV morphology. 

          Cardiovascular Ultrasound | July 07, 2022

          Automated features on the Philips EPIQ CVx cardiology ultrasound system are helping to bring consistency and speed to every echo exam. The AI-empowered algorithm delivers fast and consistent measurements – in half the time of manual methods.*  

          Watch the video to see how you can put “smart”  to work with the latest AI-powered quantification tools. 

          *External study with external sonographers comparing the results of 18 exams with and without AutoMeasure

          Cardiovascular Ultrasound | June 14, 2022

          The X5-1c transducer from Philips provides enhanced clinical information in transthoracic imaging over a standard phased array transducer. When combined with nSIGHT Plus image formation on the EPIQ CVx cardiology ultrasound system, the X5-1c transducer enables image quality rarely seen from a transthoracic transducer. 

          Watch the video to learn about the benefits which may include decreased exam time due to faster access to echo windows, increased confidence in quantification results and more. 

          Cardiovascular Ultrasound | May 31, 2022

          Philips recently announced an update to their flagship EPIQ CVx premium cardiology ultrasound system. Watch the video to learn about the latest features including the next-generation nSIGHT Plus imaging architecture system that leverages both hardware and software to support sophisticated image formation and enhanced image quality.

          Conference Coverage View all 467 items

          Cardiovascular Clinical Studies | July 30, 2024

          As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

          As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

          His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

          Related content:

          DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

          DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

           

          HIMSS | July 24, 2024

          Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

          Find more HIMSS24 conference coverage here

          A New Partnership for Growth

          Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

          Exciting New Features at HIMSS24

          At HIMSS2024, with this new collaboration comes new features, including:

          Related content:

          Find more HIMSS24 conference coverage here

          HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

          Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          Information Technology | May 17, 2023

          HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

          Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

          Find more HIMSS23 coverage here

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

           

          Related Digital Transformation Content:

          Robocath Launches New Robotic Platform R-One+

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          New ACC President Defines Priorities for Year Ahead

          Health That Connects + Tech That Cares at HIMSS 2023

          ACC22: Transforming Cardiovascular Care

           

           

          Information Technology | May 11, 2023

          Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

          Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

          Find more HIMSS23 coverage here

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          Related Digital Transformation Content:

          Robocath Launches New Robotic Platform R-One+

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          New ACC President Defines Priorities for Year Ahead

          Health That Connects + Tech That Cares at HIMSS 2023

          ACC22: Transforming Cardiovascular Care

          Cath Lab View all 316 items

          Cardiovascular Clinical Studies | July 30, 2024

          As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

          As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

          His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

          Related content:

          DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

          DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

           

          HIMSS | July 24, 2024

          Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

          Find more HIMSS24 conference coverage here

          A New Partnership for Growth

          Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

          Exciting New Features at HIMSS24

          At HIMSS2024, with this new collaboration comes new features, including:

          Related content:

          Find more HIMSS24 conference coverage here

          HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

          Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          Information Technology | May 17, 2023

          HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

          Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

          Find more HIMSS23 coverage here

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

           

          Related Digital Transformation Content:

          Robocath Launches New Robotic Platform R-One+

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          New ACC President Defines Priorities for Year Ahead

          Health That Connects + Tech That Cares at HIMSS 2023

          ACC22: Transforming Cardiovascular Care

           

           

          Information Technology | May 11, 2023

          Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

          Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

          Find more HIMSS23 coverage here

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          Related Digital Transformation Content:

          Robocath Launches New Robotic Platform R-One+

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          New ACC President Defines Priorities for Year Ahead

          Health That Connects + Tech That Cares at HIMSS 2023

          ACC22: Transforming Cardiovascular Care

          Cardiac Imaging View all 289 items

          Cardiovascular Clinical Studies | July 30, 2024

          As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

          As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

          His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

          Related content:

          DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

          DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

           

          HIMSS | July 24, 2024

          Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

          Find more HIMSS24 conference coverage here

          A New Partnership for Growth

          Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

          Exciting New Features at HIMSS24

          At HIMSS2024, with this new collaboration comes new features, including:

          Related content:

          Find more HIMSS24 conference coverage here

          HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

          Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          Information Technology | May 17, 2023

          HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

          Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

          Find more HIMSS23 coverage here

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

           

          Related Digital Transformation Content:

          Robocath Launches New Robotic Platform R-One+

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          New ACC President Defines Priorities for Year Ahead

          Health That Connects + Tech That Cares at HIMSS 2023

          ACC22: Transforming Cardiovascular Care

           

           

          Information Technology | May 11, 2023

          Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

          Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

          Find more HIMSS23 coverage here

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          Related Digital Transformation Content:

          Robocath Launches New Robotic Platform R-One+

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          New ACC President Defines Priorities for Year Ahead

          Health That Connects + Tech That Cares at HIMSS 2023

          ACC22: Transforming Cardiovascular Care

          Cardiac Diagnostics View all 78 items

          Cardiovascular Clinical Studies | July 30, 2024

          As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

          As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

          His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

          Related content:

          DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

          DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

           

          HIMSS | July 24, 2024

          Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

          Find more HIMSS24 conference coverage here

          A New Partnership for Growth

          Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

          Exciting New Features at HIMSS24

          At HIMSS2024, with this new collaboration comes new features, including:

          Related content:

          Find more HIMSS24 conference coverage here

          HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

          Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          Information Technology | May 17, 2023

          HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

          Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

          Find more HIMSS23 coverage here

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

           

          Related Digital Transformation Content:

          Robocath Launches New Robotic Platform R-One+

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          New ACC President Defines Priorities for Year Ahead

          Health That Connects + Tech That Cares at HIMSS 2023

          ACC22: Transforming Cardiovascular Care

           

           

          Information Technology | May 11, 2023

          Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

          Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

          Find more HIMSS23 coverage here

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          Related Digital Transformation Content:

          Robocath Launches New Robotic Platform R-One+

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          New ACC President Defines Priorities for Year Ahead

          Health That Connects + Tech That Cares at HIMSS 2023

          ACC22: Transforming Cardiovascular Care

          EP Lab View all 83 items

          Cardiovascular Clinical Studies | July 30, 2024

          As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

          As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

          His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

          Related content:

          DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

          DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

           

          HIMSS | July 24, 2024

          Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

          Find more HIMSS24 conference coverage here

          A New Partnership for Growth

          Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

          Exciting New Features at HIMSS24

          At HIMSS2024, with this new collaboration comes new features, including:

          Related content:

          Find more HIMSS24 conference coverage here

          HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

          Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          Information Technology | May 17, 2023

          HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

          Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

          Find more HIMSS23 coverage here

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

           

          Related Digital Transformation Content:

          Robocath Launches New Robotic Platform R-One+

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          New ACC President Defines Priorities for Year Ahead

          Health That Connects + Tech That Cares at HIMSS 2023

          ACC22: Transforming Cardiovascular Care

           

           

          Information Technology | May 11, 2023

          Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

          Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

          Find more HIMSS23 coverage here

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          Related Digital Transformation Content:

          Robocath Launches New Robotic Platform R-One+

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          New ACC President Defines Priorities for Year Ahead

          Health That Connects + Tech That Cares at HIMSS 2023

          ACC22: Transforming Cardiovascular Care

          Information Technology View all 177 items

          Cardiovascular Clinical Studies | July 30, 2024

          As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

          As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

          His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

          Related content:

          DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

          DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

           

          HIMSS | July 24, 2024

          Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

          Find more HIMSS24 conference coverage here

          A New Partnership for Growth

          Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

          Exciting New Features at HIMSS24

          At HIMSS2024, with this new collaboration comes new features, including:

          Related content:

          Find more HIMSS24 conference coverage here

          HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

          Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          Information Technology | May 17, 2023

          HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

          Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

          Find more HIMSS23 coverage here

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

           

          Related Digital Transformation Content:

          Robocath Launches New Robotic Platform R-One+

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          New ACC President Defines Priorities for Year Ahead

          Health That Connects + Tech That Cares at HIMSS 2023

          ACC22: Transforming Cardiovascular Care

           

           

          Information Technology | May 11, 2023

          Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

          Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

          Find more HIMSS23 coverage here

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          Related Digital Transformation Content:

          Robocath Launches New Robotic Platform R-One+

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          New ACC President Defines Priorities for Year Ahead

          Health That Connects + Tech That Cares at HIMSS 2023

          ACC22: Transforming Cardiovascular Care

          Todd Villines explains highlights from SCCT 2020
          Video Player is loading.
          Current Time 0:00
          Duration 6:35
          Loaded: 0%
          Stream Type LIVE
          Remaining Time 6:35
           
          1x
            • Chapters
            • descriptions off, selected
            • captions off, selected
            • en (Main), selected

            Todd Villines, M.D., FACC, FAHA, MSCCT, explains some of most influential cardiac CT clinical papers from the past year at the Society of Cardiovascular Computed Tomography (SCCT) 2020 virtual meeting. Among these were the ISCHEMIA Trial, others showing the value of CT is assessing chest pain patients and its ability to act as a gate keeper to the cath lab, and the 2019 European Society of Cardiology (ESC) guidelines that now list cardiac as a preferred imaging modality.

            Villines is the Julian Ruffin Beckwith Professor of Medicine, Division of Cardiovascular Medicine, University of Virginia, editor-in-chief of the Journal of Cardiovascular CT (JCCT), and SCCT past-president.

             

            Other Key Trends and Technology at SCCT:

            Top 9 Cardiovascular CT Studies in Past Year 

            VIDEO: Increased Use of Cardiac CT During the COVID-19 Pandemic

            VIDEO: Coronary Plaque Quantification Will Become Major Risk Assessment

            VIDEO: Photon Counting Detectors Will be the Next Major Advance in Computed Tomography

            VIDEO: Artificial Intelligence to Automate CT Calcium Scoring and Radiomics

            Low-attenuation Coronary Plaque Burden May Become Next Big Cardiac Risk Assessment

            Impact of Cardiac CT During COVID-19

             

            Recent Videos View all 660 items

            January 30, 2025

            On July 16, 2024, Diagnostic and Interventional Cardiology presented a webinar on "Maximizing Structural Heart Workflows: Harnessing the Power of CVIS and AI." 

            During the webinar, Omer Schalit–Cohen, chief product officer at Optum’s Healthcare Enterprising Imaging business unit, addressed optimizing workflow and efficiencies in the cardiovascular imaging department.  In the presentation, Cohen examines how you can harness the power of the CVIS and AI technologies to enhance structural heart workflow in the EP lab and ultrasound procedures.

            Schalit–Cohen is the chief product officer at Optum’s Healthcare Enterprising Imaging business unit. With more than 20 years of experience in innovation, he is an expert in the Imaging’s department complex workflows and has been instrumental in driving market leading solutions that have significantly enhanced patient care and department’s efficiency. as well as customer satisfaction.
             

            Company Profile

            The webinar is sponsored by Optum, a leading information and technology-enabled health services business dedicated to helping make the health system work better for everyone. With more than 215,000 people worldwide, Optum delivers intelligent, integrated solutions that help to modernize the health system and improve overall population health. Optum is part of UnitedHealth Group.

            For more information, visit optum.com.

            January 07, 2025

            On Jan. 10, 2024, Diagnostic and Interventional Cardiology presented a webinar on "Contrast Management in Modern PCI." 

            Dr. Aditya Sharma, MD, MBA, FACC, FSCAI, an interventional cardiologist from Wellspan Health in Central Pennsylvania was the presenter. The webinar is sponsored by ACIST Medical Systems.

            In the cardiac cath lab, the use of iodinated contrast in both diagnostic and PCI procedures is commonplace. The effects of iodinated contrast on renal function have been known and researched. However, conversations are ongoing around best practices and standards of care regarding contrast management and treatment for those with higher risk factors, like compromised renal function. Participate in this webinar to gain insight on the topic of contrast-induced kidney injury and how one could approach contrast management in modern PCI with use of the ACIST CVi Contrast Delivery System.

            Learning Objectives

            * Understand basic mechanisms of contrast induced kidney injury.
            * Determine incidence of disease along with long term patient and economic implications.
            * Review risk factors determining higher risk populations.
            * Evaluate device strategy in modern era to mitigate risk and promote procedural efficiency and safety.
            * Case review of use of the ACIST CVi Contrast Delivery System in high risk patient. 

            Dr. Aditya Sharma
            Dr Aditya Sharma

            Dr. Sharma is board certified in internal medicine, cardiovascular disease, and interventional cardiology, having completed both residency and fellowship programs at George Washington University - School of Medicine and Hospital. He chose a career in medicine to be able to help others while being able to continuously enrich his skills and apply learned scientific knowledge.

            About ACIST

            Physicians worldwide rely on our diagnostic technologies to give them the power to visualize, assess and inform patient treatment. ACIST informs interventional decisions during peripheral, cardiovascular disease and structural heart procedures. Economic decision-makers appreciate our ability to demonstrate the value of therapeutic intervention.

            January 01, 2025

            Preventing contrast induced nephropathy and managing patients with chronic kidney disease remain major challenges in the cardiac catheterization lab. In recent years, contrast supply shortages have presented a new challenge to care delivery. When considering these challenges, and as quality metrics in our labs face more scrutiny, there are existing technologies and best practices such as a variable rate contrast delivery systems and HD IVUS that can be used to manage workflow and improve patient outcomes.

            The ACC Interventional Council’s recent statement recommending that intracoronary imaging be a routine part of clinical practice further reinforces the need for adoption of intracoronary. Using a case-based approach, the faculty will demonstrate how to use the ACIST CVi contrast delivery system, HDi high definition IVUS and diagnostic and post-PCI physiologic assessment to reduce contrast usage, improve AKI rates and deliver optimized patient outcomes.

            Learning Objectives

            By the end of this webinar, participants will understand that high-quality care starts at the point of education and can transform cardiovascular imaging. Attendees will see how optimized workflows can improve quality and will be able to:

            • To understand the benefits of implementing a variable rate contrast delivery system in the cath lab.

            • To understand the clinical benefits of HD IVUS utilization and how to implement a standardized workflow for effective use.

            • To understand how HD IVUS and physiologic testing can be used to improve patient outcomes and reduce contrast utilization.

            Featured Speakers

            headshot

            Dr. Matheen A. Khuddus, Director of Cardiovascular Research/Director of the Cardiac Catheterization Lab, HCA Florida North Florida Hospital and the Cardiac & Vascular Institute, Gainesville, Fla.

            Dr. Khuddus is an interventional cardiologist who currently serves as the Director of Cardiovascular Research and the Director of the Cardiac Catheterization Lab as well as a National Physician Director for HCA Healthcare. He is a fellow of the ACC and SCAI.  He is board certified in Cardiovascular Medicine, Interventional Cardiology, and Internal Medicine.  He is also an AHSCP Clinical Hypertension Specialist.



            headshot

            Dr. Darshan Doshi, Director of Complex Coronary Artery Disease, Massachusetts General Hospital, Boston, Mass.

            Dr. Doshi is an interventional cardiologist who specializes in complex coronary intervention, specifically chronic total occlusions, surgical turndowns, ultralow and zero contrast stenting procedures, and treatment of recurrent stent blockages. He is the Director of Complex Coronary Artery Disease at MGH. He is board certified in Cardiovascular Medicine and Interventional Cardiology.

            About ACIST

            Physicians worldwide rely on our diagnostic technologies to give them the power to visualize, assess and inform patient treatment. ACIST informs interventional decisions during peripheral, cardiovascular disease and structural heart procedures. Economic decision-makers appreciate our ability to demonstrate the value of therapeutic intervention.

            January 24, 2025

            Behavioral science is being applied in unique ways for enterprise-imaging product design.

            Behavioral science is the study of human behavior. It’s a mix of psychology, sociology, social and cultural anthropology, and economics. Using a data-driven, human-centered approach, behavioral science helps uncover what people have done in the past and tries to predict — and often change — how they’ll behave in the future.

            In this webinar, leading healthcare experts will discuss how observation, interviews, and experimentation can help the industry form a better understanding of current customer needs and pain points within cardiovascular imaging. Having clinicians involved in the product-design process has led to the complete rearchitecting of a next-generation hemodynamics solution.

            Using a real-world scenario, we’ll share a clinician’s experience working with behavioral science and product-development teams, provide an understanding of how they’re using hemodynamics today, and get their thoughts on the future of imaging and hemodynamics.

            By listening to key stakeholders, new features can be brought to market that will have a notable impact on the way health systems operate. By building better products, we can help improve patient outcomes and ultimately transform the healthcare industry — one behavior at a time.

            Learning Objectives

            • How a next-generation hemodynamics system has implemented 19 user-centric concepts and undergone iterative testing with healthcare providers.

            • How physicians, technicians, nurses and administrators are providing their expertise to bring new features to market that will have a notable impact on the way health systems operate.

            • What a next-generation hemodynamics system can do to keep pace with new technology innovations in cardiovascular care and increasing clinical demands.

            Featured Speakers

            James Stinnett

            James Stinnett, Behavioral Scientist, Change Healthcare

            James Stinnett is an experienced researcher with a background in product, UX, and behavioral science. He joined Change Healthcare three years ago and is currently a researcher on the behavioral science team.

            Dr. Barry Bertolet

            Dr. Barry Bertolet, Interventional Cardiologist and Director of Cardiac Catheterization Laboratory, North Mississippi Medical Center

            Dr. Barry Bertolet champions the education of physicians and patients throughout the region and has participated in numerous research trials exploring early detection and treatment of cardiovascular diseases. He is a founding member of the Mississippi Health Care Alliance, an organization which has developed the nation’s first statewide system of care for both heart attack and stroke. He is also board certified by the American Board of Internal Medicine in cardiovascular disease, internal medicine and interventional cardiology.

            About Change Healthcare

            Change Healthcare is a leading independent healthcare technology company, focused on insights, innovation and accelerating the transformation of the healthcare system through the power of the Change Healthcare platform. We provide data and analytics-driven solutions to improve clinical, financial, administrative, and patient engagement outcomes in the U.S. healthcare system.

            Sponsored Videos View all 46 items

            Cardiovascular Ultrasound | July 20, 2022

            Enhanced features on the Philips EPIQ CVx ultrasound system provide a next level photorealistic 3D rendering, making it easy for users to interpret what they are seeing. The TrueVue feature enhances the sense of depth and space, producing images that appear natural and realistic to the human eye.  

            Watch the video to check out how TrueVue can help improve views of LAA and MV morphology. 

            Cardiovascular Ultrasound | July 07, 2022

            Automated features on the Philips EPIQ CVx cardiology ultrasound system are helping to bring consistency and speed to every echo exam. The AI-empowered algorithm delivers fast and consistent measurements – in half the time of manual methods.*  

            Watch the video to see how you can put “smart”  to work with the latest AI-powered quantification tools. 

            *External study with external sonographers comparing the results of 18 exams with and without AutoMeasure

            Cardiovascular Ultrasound | June 14, 2022

            The X5-1c transducer from Philips provides enhanced clinical information in transthoracic imaging over a standard phased array transducer. When combined with nSIGHT Plus image formation on the EPIQ CVx cardiology ultrasound system, the X5-1c transducer enables image quality rarely seen from a transthoracic transducer. 

            Watch the video to learn about the benefits which may include decreased exam time due to faster access to echo windows, increased confidence in quantification results and more. 

            Cardiovascular Ultrasound | May 31, 2022

            Philips recently announced an update to their flagship EPIQ CVx premium cardiology ultrasound system. Watch the video to learn about the latest features including the next-generation nSIGHT Plus imaging architecture system that leverages both hardware and software to support sophisticated image formation and enhanced image quality.

            Conference Coverage View all 467 items

            Cardiovascular Clinical Studies | July 30, 2024

            As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

            As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

            His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

            Related content:

            DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

            DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

             

            HIMSS | July 24, 2024

            Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

            Find more HIMSS24 conference coverage here

            A New Partnership for Growth

            Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

            Exciting New Features at HIMSS24

            At HIMSS2024, with this new collaboration comes new features, including:

            Related content:

            Find more HIMSS24 conference coverage here

            HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

            Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

            VIDEO: Using Maturity Models to Measure Digital Health

            VIDEO: Moving Digital Transformation Forward in Healthcare

            VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

            VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

            VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

            Information Technology | May 17, 2023

            HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

            Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

            Find more HIMSS23 coverage here

            VIDEO: Moving Digital Transformation Forward in Healthcare

            VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

            VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

            VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

             

            Related Digital Transformation Content:

            Robocath Launches New Robotic Platform R-One+

            VIDEO: Using Maturity Models to Measure Digital Health

            VIDEO: Moving Digital Transformation Forward in Healthcare

            VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

            VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

            VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

            New ACC President Defines Priorities for Year Ahead

            Health That Connects + Tech That Cares at HIMSS 2023

            ACC22: Transforming Cardiovascular Care

             

             

            Information Technology | May 11, 2023

            Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

            Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

            Find more HIMSS23 coverage here

            VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

            VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

            VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

            Related Digital Transformation Content:

            Robocath Launches New Robotic Platform R-One+

            VIDEO: Using Maturity Models to Measure Digital Health

            VIDEO: Moving Digital Transformation Forward in Healthcare

            VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

            VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

            VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

            New ACC President Defines Priorities for Year Ahead

            Health That Connects + Tech That Cares at HIMSS 2023

            ACC22: Transforming Cardiovascular Care

            Cath Lab View all 316 items

            Cardiovascular Clinical Studies | July 30, 2024

            As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

            As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

            His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

            Related content:

            DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

            DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

             

            HIMSS | July 24, 2024

            Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

            Find more HIMSS24 conference coverage here

            A New Partnership for Growth

            Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

            Exciting New Features at HIMSS24

            At HIMSS2024, with this new collaboration comes new features, including:

            Related content:

            Find more HIMSS24 conference coverage here

            HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

            Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

            VIDEO: Using Maturity Models to Measure Digital Health

            VIDEO: Moving Digital Transformation Forward in Healthcare

            VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

            VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

            VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

            Information Technology | May 17, 2023

            HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

            Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

            Find more HIMSS23 coverage here

            VIDEO: Moving Digital Transformation Forward in Healthcare

            VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

            VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

            VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

             

            Related Digital Transformation Content:

            Robocath Launches New Robotic Platform R-One+

            VIDEO: Using Maturity Models to Measure Digital Health

            VIDEO: Moving Digital Transformation Forward in Healthcare

            VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

            VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

            VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

            New ACC President Defines Priorities for Year Ahead

            Health That Connects + Tech That Cares at HIMSS 2023

            ACC22: Transforming Cardiovascular Care

             

             

            Information Technology | May 11, 2023

            Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

            Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

            Find more HIMSS23 coverage here

            VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

            VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

            VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

            Related Digital Transformation Content:

            Robocath Launches New Robotic Platform R-One+

            VIDEO: Using Maturity Models to Measure Digital Health

            VIDEO: Moving Digital Transformation Forward in Healthcare

            VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

            VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

            VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

            New ACC President Defines Priorities for Year Ahead

            Health That Connects + Tech That Cares at HIMSS 2023

            ACC22: Transforming Cardiovascular Care

            Cardiac Imaging View all 289 items

            Cardiovascular Clinical Studies | July 30, 2024

            As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

            As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

            His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

            Related content:

            DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

            DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

             

            HIMSS | July 24, 2024

            Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

            Find more HIMSS24 conference coverage here

            A New Partnership for Growth

            Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

            Exciting New Features at HIMSS24

            At HIMSS2024, with this new collaboration comes new features, including:

            Related content:

            Find more HIMSS24 conference coverage here

            HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

            Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

            VIDEO: Using Maturity Models to Measure Digital Health

            VIDEO: Moving Digital Transformation Forward in Healthcare

            VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

            VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

            VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

            Information Technology | May 17, 2023

            HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

            Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

            Find more HIMSS23 coverage here

            VIDEO: Moving Digital Transformation Forward in Healthcare

            VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

            VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

            VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

             

            Related Digital Transformation Content:

            Robocath Launches New Robotic Platform R-One+

            VIDEO: Using Maturity Models to Measure Digital Health

            VIDEO: Moving Digital Transformation Forward in Healthcare

            VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

            VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

            VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

            New ACC President Defines Priorities for Year Ahead

            Health That Connects + Tech That Cares at HIMSS 2023

            ACC22: Transforming Cardiovascular Care

             

             

            Information Technology | May 11, 2023

            Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

            Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

            Find more HIMSS23 coverage here

            VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

            VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

            VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

            Related Digital Transformation Content:

            Robocath Launches New Robotic Platform R-One+

            VIDEO: Using Maturity Models to Measure Digital Health

            VIDEO: Moving Digital Transformation Forward in Healthcare

            VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

            VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

            VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

            New ACC President Defines Priorities for Year Ahead

            Health That Connects + Tech That Cares at HIMSS 2023

            ACC22: Transforming Cardiovascular Care

            Cardiac Diagnostics View all 78 items

            Cardiovascular Clinical Studies | July 30, 2024

            As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

            As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

            His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

            Related content:

            DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

            DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

             

            HIMSS | July 24, 2024

            Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

            Find more HIMSS24 conference coverage here

            A New Partnership for Growth

            Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

            Exciting New Features at HIMSS24

            At HIMSS2024, with this new collaboration comes new features, including:

            Related content:

            Find more HIMSS24 conference coverage here

            HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

            Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

            VIDEO: Using Maturity Models to Measure Digital Health

            VIDEO: Moving Digital Transformation Forward in Healthcare

            VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

            VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

            VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

            Information Technology | May 17, 2023

            HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

            Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

            Find more HIMSS23 coverage here

            VIDEO: Moving Digital Transformation Forward in Healthcare

            VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

            VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

            VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

             

            Related Digital Transformation Content:

            Robocath Launches New Robotic Platform R-One+

            VIDEO: Using Maturity Models to Measure Digital Health

            VIDEO: Moving Digital Transformation Forward in Healthcare

            VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

            VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

            VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

            New ACC President Defines Priorities for Year Ahead

            Health That Connects + Tech That Cares at HIMSS 2023

            ACC22: Transforming Cardiovascular Care

             

             

            Information Technology | May 11, 2023

            Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

            Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

            Find more HIMSS23 coverage here

            VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

            VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

            VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

            Related Digital Transformation Content:

            Robocath Launches New Robotic Platform R-One+

            VIDEO: Using Maturity Models to Measure Digital Health

            VIDEO: Moving Digital Transformation Forward in Healthcare

            VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

            VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

            VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

            New ACC President Defines Priorities for Year Ahead

            Health That Connects + Tech That Cares at HIMSS 2023

            ACC22: Transforming Cardiovascular Care

            EP Lab View all 83 items

            Cardiovascular Clinical Studies | July 30, 2024

            As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

            As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

            His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

            Related content:

            DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

            DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

             

            HIMSS | July 24, 2024

            Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

            Find more HIMSS24 conference coverage here

            A New Partnership for Growth

            Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

            Exciting New Features at HIMSS24

            At HIMSS2024, with this new collaboration comes new features, including:

            Related content:

            Find more HIMSS24 conference coverage here

            HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

            Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

            VIDEO: Using Maturity Models to Measure Digital Health

            VIDEO: Moving Digital Transformation Forward in Healthcare

            VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

            VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

            VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

            Information Technology | May 17, 2023

            HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

            Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

            Find more HIMSS23 coverage here

            VIDEO: Moving Digital Transformation Forward in Healthcare

            VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

            VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

            VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

             

            Related Digital Transformation Content:

            Robocath Launches New Robotic Platform R-One+

            VIDEO: Using Maturity Models to Measure Digital Health

            VIDEO: Moving Digital Transformation Forward in Healthcare

            VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

            VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

            VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

            New ACC President Defines Priorities for Year Ahead

            Health That Connects + Tech That Cares at HIMSS 2023

            ACC22: Transforming Cardiovascular Care

             

             

            Information Technology | May 11, 2023

            Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

            Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

            Find more HIMSS23 coverage here

            VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

            VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

            VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

            Related Digital Transformation Content:

            Robocath Launches New Robotic Platform R-One+

            VIDEO: Using Maturity Models to Measure Digital Health

            VIDEO: Moving Digital Transformation Forward in Healthcare

            VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

            VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

            VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

            New ACC President Defines Priorities for Year Ahead

            Health That Connects + Tech That Cares at HIMSS 2023

            ACC22: Transforming Cardiovascular Care

            Information Technology View all 177 items

            Cardiovascular Clinical Studies | July 30, 2024

            As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

            As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

            His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

            Related content:

            DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

            DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

             

            HIMSS | July 24, 2024

            Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

            Find more HIMSS24 conference coverage here

            A New Partnership for Growth

            Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

            Exciting New Features at HIMSS24

            At HIMSS2024, with this new collaboration comes new features, including:

            Related content:

            Find more HIMSS24 conference coverage here

            HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

            Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

            VIDEO: Using Maturity Models to Measure Digital Health

            VIDEO: Moving Digital Transformation Forward in Healthcare

            VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

            VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

            VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

            Information Technology | May 17, 2023

            HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

            Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

            Find more HIMSS23 coverage here

            VIDEO: Moving Digital Transformation Forward in Healthcare

            VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

            VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

            VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

             

            Related Digital Transformation Content:

            Robocath Launches New Robotic Platform R-One+

            VIDEO: Using Maturity Models to Measure Digital Health

            VIDEO: Moving Digital Transformation Forward in Healthcare

            VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

            VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

            VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

            New ACC President Defines Priorities for Year Ahead

            Health That Connects + Tech That Cares at HIMSS 2023

            ACC22: Transforming Cardiovascular Care

             

             

            Information Technology | May 11, 2023

            Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

            Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

            Find more HIMSS23 coverage here

            VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

            VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

            VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

            Related Digital Transformation Content:

            Robocath Launches New Robotic Platform R-One+

            VIDEO: Using Maturity Models to Measure Digital Health

            VIDEO: Moving Digital Transformation Forward in Healthcare

            VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

            VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

            VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

            New ACC President Defines Priorities for Year Ahead

            Health That Connects + Tech That Cares at HIMSS 2023

            ACC22: Transforming Cardiovascular Care

            Todd Villines explains trend in CT plaque attenuation risk assessments 2
            Video Player is loading.
            Current Time 0:00
            Duration 0:00
            Loaded: 0%
            Stream Type LIVE
            Remaining Time 0:00
             
            1x
              • Chapters
              • descriptions off, selected
              • captions off, selected

                Todd Villines, M.D., FACC, FAHA, MSCCT, explains how coronary plaque assessment will become a new risk assessment tool in cardiac CT. This was a key take away during the Society of Cardiovascular Computed Tomography (SCCT) 2020 virtual meeting in July. He is the Julian Ruffin Beckwith Professor of Medicine, Division of Cardiovascular Medicine, University of Virginia; editor-in-chief of the Journal of Cardiovascular CT (JCCT), and SCCT past-president. 

                While basic plaque assessments have been available for several years on CT vendor and third-party advanced visualization software, it lacked automation standardization for what various values meant and clinical evidence it was relevant. However, several speakers in SCCT sessions said that is now changing, with more specific analysis being tested clinically and automation using artificial intelligence. 

                Several key opinion leaders in cardiac CT said this new information and automation will likely lead to a revision of the current CAD-RADS scoring system used by radiologists and cardiologists when assessing the coronary event risk of patients. They are calling for the new CAD-RADS 2.0 to include a detailed plaque assessment.  

                 

                Related SCCT Key Trends and New Technology Content:

                Low-attenuation Coronary Plaque Burden May Become Next Big Cardiac Risk Assessment

                Top 9 Cardiovascular CT Studies in Past Year 

                VIDEO: Increased Use of Cardiac CT During the COVID-19 Pandemic

                VIDEO: Key Cardiac CT Papers Presented at SCCT 2020

                VIDEO: Photon Counting Detectors Will be the Next Major Advance in Computed Tomography

                VIDEO: Artificial Intelligence to Automate CT Calcium Scoring and Radiomics 

                Impact of Cardiac CT During COVID-19
                 

                Recent Videos View all 660 items

                January 30, 2025

                On July 16, 2024, Diagnostic and Interventional Cardiology presented a webinar on "Maximizing Structural Heart Workflows: Harnessing the Power of CVIS and AI." 

                During the webinar, Omer Schalit–Cohen, chief product officer at Optum’s Healthcare Enterprising Imaging business unit, addressed optimizing workflow and efficiencies in the cardiovascular imaging department.  In the presentation, Cohen examines how you can harness the power of the CVIS and AI technologies to enhance structural heart workflow in the EP lab and ultrasound procedures.

                Schalit–Cohen is the chief product officer at Optum’s Healthcare Enterprising Imaging business unit. With more than 20 years of experience in innovation, he is an expert in the Imaging’s department complex workflows and has been instrumental in driving market leading solutions that have significantly enhanced patient care and department’s efficiency. as well as customer satisfaction.
                 

                Company Profile

                The webinar is sponsored by Optum, a leading information and technology-enabled health services business dedicated to helping make the health system work better for everyone. With more than 215,000 people worldwide, Optum delivers intelligent, integrated solutions that help to modernize the health system and improve overall population health. Optum is part of UnitedHealth Group.

                For more information, visit optum.com.

                January 07, 2025

                On Jan. 10, 2024, Diagnostic and Interventional Cardiology presented a webinar on "Contrast Management in Modern PCI." 

                Dr. Aditya Sharma, MD, MBA, FACC, FSCAI, an interventional cardiologist from Wellspan Health in Central Pennsylvania was the presenter. The webinar is sponsored by ACIST Medical Systems.

                In the cardiac cath lab, the use of iodinated contrast in both diagnostic and PCI procedures is commonplace. The effects of iodinated contrast on renal function have been known and researched. However, conversations are ongoing around best practices and standards of care regarding contrast management and treatment for those with higher risk factors, like compromised renal function. Participate in this webinar to gain insight on the topic of contrast-induced kidney injury and how one could approach contrast management in modern PCI with use of the ACIST CVi Contrast Delivery System.

                Learning Objectives

                * Understand basic mechanisms of contrast induced kidney injury.
                * Determine incidence of disease along with long term patient and economic implications.
                * Review risk factors determining higher risk populations.
                * Evaluate device strategy in modern era to mitigate risk and promote procedural efficiency and safety.
                * Case review of use of the ACIST CVi Contrast Delivery System in high risk patient. 

                Dr. Aditya Sharma
                Dr Aditya Sharma

                Dr. Sharma is board certified in internal medicine, cardiovascular disease, and interventional cardiology, having completed both residency and fellowship programs at George Washington University - School of Medicine and Hospital. He chose a career in medicine to be able to help others while being able to continuously enrich his skills and apply learned scientific knowledge.

                About ACIST

                Physicians worldwide rely on our diagnostic technologies to give them the power to visualize, assess and inform patient treatment. ACIST informs interventional decisions during peripheral, cardiovascular disease and structural heart procedures. Economic decision-makers appreciate our ability to demonstrate the value of therapeutic intervention.

                January 01, 2025

                Preventing contrast induced nephropathy and managing patients with chronic kidney disease remain major challenges in the cardiac catheterization lab. In recent years, contrast supply shortages have presented a new challenge to care delivery. When considering these challenges, and as quality metrics in our labs face more scrutiny, there are existing technologies and best practices such as a variable rate contrast delivery systems and HD IVUS that can be used to manage workflow and improve patient outcomes.

                The ACC Interventional Council’s recent statement recommending that intracoronary imaging be a routine part of clinical practice further reinforces the need for adoption of intracoronary. Using a case-based approach, the faculty will demonstrate how to use the ACIST CVi contrast delivery system, HDi high definition IVUS and diagnostic and post-PCI physiologic assessment to reduce contrast usage, improve AKI rates and deliver optimized patient outcomes.

                Learning Objectives

                By the end of this webinar, participants will understand that high-quality care starts at the point of education and can transform cardiovascular imaging. Attendees will see how optimized workflows can improve quality and will be able to:

                • To understand the benefits of implementing a variable rate contrast delivery system in the cath lab.

                • To understand the clinical benefits of HD IVUS utilization and how to implement a standardized workflow for effective use.

                • To understand how HD IVUS and physiologic testing can be used to improve patient outcomes and reduce contrast utilization.

                Featured Speakers

                headshot

                Dr. Matheen A. Khuddus, Director of Cardiovascular Research/Director of the Cardiac Catheterization Lab, HCA Florida North Florida Hospital and the Cardiac & Vascular Institute, Gainesville, Fla.

                Dr. Khuddus is an interventional cardiologist who currently serves as the Director of Cardiovascular Research and the Director of the Cardiac Catheterization Lab as well as a National Physician Director for HCA Healthcare. He is a fellow of the ACC and SCAI.  He is board certified in Cardiovascular Medicine, Interventional Cardiology, and Internal Medicine.  He is also an AHSCP Clinical Hypertension Specialist.



                headshot

                Dr. Darshan Doshi, Director of Complex Coronary Artery Disease, Massachusetts General Hospital, Boston, Mass.

                Dr. Doshi is an interventional cardiologist who specializes in complex coronary intervention, specifically chronic total occlusions, surgical turndowns, ultralow and zero contrast stenting procedures, and treatment of recurrent stent blockages. He is the Director of Complex Coronary Artery Disease at MGH. He is board certified in Cardiovascular Medicine and Interventional Cardiology.

                About ACIST

                Physicians worldwide rely on our diagnostic technologies to give them the power to visualize, assess and inform patient treatment. ACIST informs interventional decisions during peripheral, cardiovascular disease and structural heart procedures. Economic decision-makers appreciate our ability to demonstrate the value of therapeutic intervention.

                January 24, 2025

                Behavioral science is being applied in unique ways for enterprise-imaging product design.

                Behavioral science is the study of human behavior. It’s a mix of psychology, sociology, social and cultural anthropology, and economics. Using a data-driven, human-centered approach, behavioral science helps uncover what people have done in the past and tries to predict — and often change — how they’ll behave in the future.

                In this webinar, leading healthcare experts will discuss how observation, interviews, and experimentation can help the industry form a better understanding of current customer needs and pain points within cardiovascular imaging. Having clinicians involved in the product-design process has led to the complete rearchitecting of a next-generation hemodynamics solution.

                Using a real-world scenario, we’ll share a clinician’s experience working with behavioral science and product-development teams, provide an understanding of how they’re using hemodynamics today, and get their thoughts on the future of imaging and hemodynamics.

                By listening to key stakeholders, new features can be brought to market that will have a notable impact on the way health systems operate. By building better products, we can help improve patient outcomes and ultimately transform the healthcare industry — one behavior at a time.

                Learning Objectives

                • How a next-generation hemodynamics system has implemented 19 user-centric concepts and undergone iterative testing with healthcare providers.

                • How physicians, technicians, nurses and administrators are providing their expertise to bring new features to market that will have a notable impact on the way health systems operate.

                • What a next-generation hemodynamics system can do to keep pace with new technology innovations in cardiovascular care and increasing clinical demands.

                Featured Speakers

                James Stinnett

                James Stinnett, Behavioral Scientist, Change Healthcare

                James Stinnett is an experienced researcher with a background in product, UX, and behavioral science. He joined Change Healthcare three years ago and is currently a researcher on the behavioral science team.

                Dr. Barry Bertolet

                Dr. Barry Bertolet, Interventional Cardiologist and Director of Cardiac Catheterization Laboratory, North Mississippi Medical Center

                Dr. Barry Bertolet champions the education of physicians and patients throughout the region and has participated in numerous research trials exploring early detection and treatment of cardiovascular diseases. He is a founding member of the Mississippi Health Care Alliance, an organization which has developed the nation’s first statewide system of care for both heart attack and stroke. He is also board certified by the American Board of Internal Medicine in cardiovascular disease, internal medicine and interventional cardiology.

                About Change Healthcare

                Change Healthcare is a leading independent healthcare technology company, focused on insights, innovation and accelerating the transformation of the healthcare system through the power of the Change Healthcare platform. We provide data and analytics-driven solutions to improve clinical, financial, administrative, and patient engagement outcomes in the U.S. healthcare system.

                Sponsored Videos View all 46 items

                Cardiovascular Ultrasound | July 20, 2022

                Enhanced features on the Philips EPIQ CVx ultrasound system provide a next level photorealistic 3D rendering, making it easy for users to interpret what they are seeing. The TrueVue feature enhances the sense of depth and space, producing images that appear natural and realistic to the human eye.  

                Watch the video to check out how TrueVue can help improve views of LAA and MV morphology. 

                Cardiovascular Ultrasound | July 07, 2022

                Automated features on the Philips EPIQ CVx cardiology ultrasound system are helping to bring consistency and speed to every echo exam. The AI-empowered algorithm delivers fast and consistent measurements – in half the time of manual methods.*  

                Watch the video to see how you can put “smart”  to work with the latest AI-powered quantification tools. 

                *External study with external sonographers comparing the results of 18 exams with and without AutoMeasure

                Cardiovascular Ultrasound | June 14, 2022

                The X5-1c transducer from Philips provides enhanced clinical information in transthoracic imaging over a standard phased array transducer. When combined with nSIGHT Plus image formation on the EPIQ CVx cardiology ultrasound system, the X5-1c transducer enables image quality rarely seen from a transthoracic transducer. 

                Watch the video to learn about the benefits which may include decreased exam time due to faster access to echo windows, increased confidence in quantification results and more. 

                Cardiovascular Ultrasound | May 31, 2022

                Philips recently announced an update to their flagship EPIQ CVx premium cardiology ultrasound system. Watch the video to learn about the latest features including the next-generation nSIGHT Plus imaging architecture system that leverages both hardware and software to support sophisticated image formation and enhanced image quality.

                Conference Coverage View all 467 items

                Cardiovascular Clinical Studies | July 30, 2024

                As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

                As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

                His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

                Related content:

                DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

                DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

                 

                HIMSS | July 24, 2024

                Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

                Find more HIMSS24 conference coverage here

                A New Partnership for Growth

                Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

                Exciting New Features at HIMSS24

                At HIMSS2024, with this new collaboration comes new features, including:

                Related content:

                Find more HIMSS24 conference coverage here

                HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

                Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

                VIDEO: Using Maturity Models to Measure Digital Health

                VIDEO: Moving Digital Transformation Forward in Healthcare

                VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

                VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

                VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

                Information Technology | May 17, 2023

                HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

                Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

                Find more HIMSS23 coverage here

                VIDEO: Moving Digital Transformation Forward in Healthcare

                VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

                VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

                VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

                 

                Related Digital Transformation Content:

                Robocath Launches New Robotic Platform R-One+

                VIDEO: Using Maturity Models to Measure Digital Health

                VIDEO: Moving Digital Transformation Forward in Healthcare

                VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

                VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

                VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

                New ACC President Defines Priorities for Year Ahead

                Health That Connects + Tech That Cares at HIMSS 2023

                ACC22: Transforming Cardiovascular Care

                 

                 

                Information Technology | May 11, 2023

                Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

                Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

                Find more HIMSS23 coverage here

                VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

                VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

                VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

                Related Digital Transformation Content:

                Robocath Launches New Robotic Platform R-One+

                VIDEO: Using Maturity Models to Measure Digital Health

                VIDEO: Moving Digital Transformation Forward in Healthcare

                VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

                VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

                VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

                New ACC President Defines Priorities for Year Ahead

                Health That Connects + Tech That Cares at HIMSS 2023

                ACC22: Transforming Cardiovascular Care

                Cath Lab View all 316 items

                Cardiovascular Clinical Studies | July 30, 2024

                As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

                As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

                His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

                Related content:

                DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

                DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

                 

                HIMSS | July 24, 2024

                Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

                Find more HIMSS24 conference coverage here

                A New Partnership for Growth

                Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

                Exciting New Features at HIMSS24

                At HIMSS2024, with this new collaboration comes new features, including:

                Related content:

                Find more HIMSS24 conference coverage here

                HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

                Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

                VIDEO: Using Maturity Models to Measure Digital Health

                VIDEO: Moving Digital Transformation Forward in Healthcare

                VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

                VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

                VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

                Information Technology | May 17, 2023

                HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

                Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

                Find more HIMSS23 coverage here

                VIDEO: Moving Digital Transformation Forward in Healthcare

                VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

                VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

                VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

                 

                Related Digital Transformation Content:

                Robocath Launches New Robotic Platform R-One+

                VIDEO: Using Maturity Models to Measure Digital Health

                VIDEO: Moving Digital Transformation Forward in Healthcare

                VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

                VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

                VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

                New ACC President Defines Priorities for Year Ahead

                Health That Connects + Tech That Cares at HIMSS 2023

                ACC22: Transforming Cardiovascular Care

                 

                 

                Information Technology | May 11, 2023

                Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

                Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

                Find more HIMSS23 coverage here

                VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

                VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

                VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

                Related Digital Transformation Content:

                Robocath Launches New Robotic Platform R-One+

                VIDEO: Using Maturity Models to Measure Digital Health

                VIDEO: Moving Digital Transformation Forward in Healthcare

                VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

                VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

                VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

                New ACC President Defines Priorities for Year Ahead

                Health That Connects + Tech That Cares at HIMSS 2023

                ACC22: Transforming Cardiovascular Care

                Cardiac Imaging View all 289 items

                Cardiovascular Clinical Studies | July 30, 2024

                As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

                As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

                His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

                Related content:

                DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

                DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

                 

                HIMSS | July 24, 2024

                Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

                Find more HIMSS24 conference coverage here

                A New Partnership for Growth

                Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

                Exciting New Features at HIMSS24

                At HIMSS2024, with this new collaboration comes new features, including:

                Related content:

                Find more HIMSS24 conference coverage here

                HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

                Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

                VIDEO: Using Maturity Models to Measure Digital Health

                VIDEO: Moving Digital Transformation Forward in Healthcare

                VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

                VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

                VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

                Information Technology | May 17, 2023

                HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

                Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

                Find more HIMSS23 coverage here

                VIDEO: Moving Digital Transformation Forward in Healthcare

                VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

                VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

                VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

                 

                Related Digital Transformation Content:

                Robocath Launches New Robotic Platform R-One+

                VIDEO: Using Maturity Models to Measure Digital Health

                VIDEO: Moving Digital Transformation Forward in Healthcare

                VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

                VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

                VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

                New ACC President Defines Priorities for Year Ahead

                Health That Connects + Tech That Cares at HIMSS 2023

                ACC22: Transforming Cardiovascular Care

                 

                 

                Information Technology | May 11, 2023

                Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

                Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

                Find more HIMSS23 coverage here

                VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

                VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

                VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

                Related Digital Transformation Content:

                Robocath Launches New Robotic Platform R-One+

                VIDEO: Using Maturity Models to Measure Digital Health

                VIDEO: Moving Digital Transformation Forward in Healthcare

                VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

                VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

                VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

                New ACC President Defines Priorities for Year Ahead

                Health That Connects + Tech That Cares at HIMSS 2023

                ACC22: Transforming Cardiovascular Care

                Cardiac Diagnostics View all 78 items

                Cardiovascular Clinical Studies | July 30, 2024

                As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

                As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

                His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

                Related content:

                DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

                DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

                 

                HIMSS | July 24, 2024

                Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

                Find more HIMSS24 conference coverage here

                A New Partnership for Growth

                Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

                Exciting New Features at HIMSS24

                At HIMSS2024, with this new collaboration comes new features, including:

                Related content:

                Find more HIMSS24 conference coverage here

                HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

                Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

                VIDEO: Using Maturity Models to Measure Digital Health

                VIDEO: Moving Digital Transformation Forward in Healthcare

                VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

                VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

                VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

                Information Technology | May 17, 2023

                HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

                Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

                Find more HIMSS23 coverage here

                VIDEO: Moving Digital Transformation Forward in Healthcare

                VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

                VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

                VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

                 

                Related Digital Transformation Content:

                Robocath Launches New Robotic Platform R-One+

                VIDEO: Using Maturity Models to Measure Digital Health

                VIDEO: Moving Digital Transformation Forward in Healthcare

                VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

                VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

                VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

                New ACC President Defines Priorities for Year Ahead

                Health That Connects + Tech That Cares at HIMSS 2023

                ACC22: Transforming Cardiovascular Care

                 

                 

                Information Technology | May 11, 2023

                Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

                Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

                Find more HIMSS23 coverage here

                VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

                VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

                VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

                Related Digital Transformation Content:

                Robocath Launches New Robotic Platform R-One+

                VIDEO: Using Maturity Models to Measure Digital Health

                VIDEO: Moving Digital Transformation Forward in Healthcare

                VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

                VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

                VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

                New ACC President Defines Priorities for Year Ahead

                Health That Connects + Tech That Cares at HIMSS 2023

                ACC22: Transforming Cardiovascular Care

                EP Lab View all 83 items

                Cardiovascular Clinical Studies | July 30, 2024

                As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

                As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

                His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

                Related content:

                DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

                DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

                 

                HIMSS | July 24, 2024

                Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

                Find more HIMSS24 conference coverage here

                A New Partnership for Growth

                Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

                Exciting New Features at HIMSS24

                At HIMSS2024, with this new collaboration comes new features, including:

                Related content:

                Find more HIMSS24 conference coverage here

                HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

                Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

                VIDEO: Using Maturity Models to Measure Digital Health

                VIDEO: Moving Digital Transformation Forward in Healthcare

                VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

                VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

                VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

                Information Technology | May 17, 2023

                HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

                Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

                Find more HIMSS23 coverage here

                VIDEO: Moving Digital Transformation Forward in Healthcare

                VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

                VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

                VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

                 

                Related Digital Transformation Content:

                Robocath Launches New Robotic Platform R-One+

                VIDEO: Using Maturity Models to Measure Digital Health

                VIDEO: Moving Digital Transformation Forward in Healthcare

                VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

                VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

                VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

                New ACC President Defines Priorities for Year Ahead

                Health That Connects + Tech That Cares at HIMSS 2023

                ACC22: Transforming Cardiovascular Care

                 

                 

                Information Technology | May 11, 2023

                Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

                Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

                Find more HIMSS23 coverage here

                VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

                VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

                VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

                Related Digital Transformation Content:

                Robocath Launches New Robotic Platform R-One+

                VIDEO: Using Maturity Models to Measure Digital Health

                VIDEO: Moving Digital Transformation Forward in Healthcare

                VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

                VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

                VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

                New ACC President Defines Priorities for Year Ahead

                Health That Connects + Tech That Cares at HIMSS 2023

                ACC22: Transforming Cardiovascular Care

                Information Technology View all 177 items

                Cardiovascular Clinical Studies | July 30, 2024

                As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

                As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

                His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

                Related content:

                DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

                DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

                 

                HIMSS | July 24, 2024

                Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

                Find more HIMSS24 conference coverage here

                A New Partnership for Growth

                Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

                Exciting New Features at HIMSS24

                At HIMSS2024, with this new collaboration comes new features, including:

                Related content:

                Find more HIMSS24 conference coverage here

                HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

                Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

                VIDEO: Using Maturity Models to Measure Digital Health

                VIDEO: Moving Digital Transformation Forward in Healthcare

                VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

                VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

                VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

                Information Technology | May 17, 2023

                HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

                Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

                Find more HIMSS23 coverage here

                VIDEO: Moving Digital Transformation Forward in Healthcare

                VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

                VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

                VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

                 

                Related Digital Transformation Content:

                Robocath Launches New Robotic Platform R-One+

                VIDEO: Using Maturity Models to Measure Digital Health

                VIDEO: Moving Digital Transformation Forward in Healthcare

                VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

                VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

                VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

                New ACC President Defines Priorities for Year Ahead

                Health That Connects + Tech That Cares at HIMSS 2023

                ACC22: Transforming Cardiovascular Care

                 

                 

                Information Technology | May 11, 2023

                Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

                Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

                Find more HIMSS23 coverage here

                VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

                VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

                VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

                Related Digital Transformation Content:

                Robocath Launches New Robotic Platform R-One+

                VIDEO: Using Maturity Models to Measure Digital Health

                VIDEO: Moving Digital Transformation Forward in Healthcare

                VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

                VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

                VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

                New ACC President Defines Priorities for Year Ahead

                Health That Connects + Tech That Cares at HIMSS 2023

                ACC22: Transforming Cardiovascular Care

                Subscribe Now